COMMISSION STAFF WORKING DOCUMENT Accompanying the document Report from the Commission to the European Parliament and the Council Implementation of the third Programme of Community action in the field of health in 2015
Date: 2018-12-12
Institutions: Directorate-General for Health and Food Safety, European Commission
Subjects: EU aid, EU migration policy, EU programme, aid to refugees, disease prevention, health care, health care system, programme budgeting, project evaluation, public health

EN 

  EN 

   EUROPEAN COMMISSION  Brussels, 12.12.2018  SWD(2018) 489 final  COMMISSION STAFF WORKING DOCUMENT Accompanying the document Report from the Commission to the European Parliament and the Council Implementation of the third Programme of Community action in the field of health in 2015 {COM(2018) 818 final}  
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE OF CONTENTS 

INTRODUCTION ................................................................................................................................... 4 

JOINT ACTIONS.................................................................................................................................... 5 

ORPHANET ........................................................................................................................................ 5 

PROJECTS .............................................................................................................................................. 6 

1.  EUReMS – European Register for Multiple Sclerosis – A tool to assess, compare and enhance 
the status of people with Multiple Sclerosis throughout the EU ......................................................... 6 

2.  EPIRARE – European Platform for Rare Disease Registries ...................................................... 7 

3.  EURO-WABB  –  EU  Rare  Diseases  Registry  for  Wolfram  syndrome,  Alström  syndrome, 
Bardet-Biedl syndrome and other rare diabetes syndromes ................................................................ 9 

4.  EUREGENAS – European Regions enforcing Actions against Suicide ................................... 10 

5.  SIALON  II  –  Capacity  building  in  combining  targeted  prevention  with  meaningful  HIV 
surveillance among MSM ................................................................................................................. 12 

6.  Special Call: Support Member States to migratory pressure in their response to health related 
challenges .......................................................................................................................................... 13 

7. 

8 NGOs in 11 States .................................................................................................................. 13 

8.  SH-CAPAC – Supporting health coordination, assessments, planning, access to health care and 
capacity building in Member States .................................................................................................. 15 

9.  EUR-HUMAN – European Refugees – Human Movement and Advisory Network ................ 16 

10. 

CARE - Common Action for Refugees and other migrants’ health ...................................... 18 

OPERATING GRANTS ....................................................................................................................... 20 

1.  EURORDIS FY2015 -2018 European Organisation for Rare Diseases .................................... 21 

DIRECT GRANTS WITH INTERNATIONAL ORGANISATIONS ................................................. 24 

1.  OECD-PS  –  DATA  AND  ANALYSIS  OF  DATA  ON  PATIENT  SAFETY  WITHIN  THE 
OECD HEALTH CARE QUALITY INDICATORS PROJECT ...................................................... 24 

2.  OECD-HWF – Feasibility study for an international survey of health workers’ skills ............. 26 

3.  OECD-EOP – Economics of Prevention ................................................................................... 27 

IOM  -  RE-HEALTH  -  Support  Member  States  under  particular  migratory  pressure  in  their 
4. 
response to health related challenges ................................................................................................ 28 

2 

 
 
 
CALLS FOR TENDERS ....................................................................................................................... 30 

1.  SERVICE  CONTRACT:  Life  Table  Analysis:  health  system  cost  effectiveness  assessments 
across Europe .................................................................................................................................... 30 

2.  SERVICE  CONTRACT:  The  review  and  mapping  of  continuous  professional  development 
and lifelong learning for health professionals in the EU ................................................................... 31 

3.  SERVICE CONTRACT: Recruitment and Retention of the Health Workforce in Europe ...... 32 

4.  SERVICE  CONTRACT:  EUREST  -  Study  on  the development  of  an  EU  common  reporting 
format  for  submission  of  data  on  ingredients  contained  in  tobacco  and  related  products,  and 
disclosure of the collected data to the public ..................................................................................... 32 

5.  SERVICE CONTRACT: Tobacco tracking & tracing .............................................................. 34 

6.  SERVICE  CONTRACT:  Economic  landscapes  of  human  tissues  and  cells  for  clinical 
application in the EU ......................................................................................................................... 36 

HIGHLIGHTS OF CO-FUNDED ‘CROSS-CUTTING’ AND ‘OTHER’ ACTIONS ......................... 38 

1.  Dissemination activities carried out in 2015 ............................................................................. 38 

2.  Other Actions ............................................................................................................................ 39 

Scientific Committees .................................................................................................................... 39 

Expert Panel of Health .................................................................................................................. 41 

Expert Panel on effective ways of investing in health ................................................................... 41 

IMPLEMENTATION OF ANNUAL WORK PROGRAMME 2015 ............................................. 43 

CALLS FOR PROPOSALS ............................................................................................................... 43 

Project grants .................................................................................................................................... 44 

Operating grants ............................................................................................................................... 47 

Joint actions ...................................................................................................................................... 50 

Direct grant agreements and Presidency Conferences ................................................................... 53 

Procurements (service contracts) ..................................................................................................... 56 

Other actions ..................................................................................................................................... 67 

DETAILED OVERVIEW OF THE REPORTING YEAR ................................................................... 69 

1.  Funding per thematic priority and financial instrument ............................................................ 69 

3 

 
 
 
INTRODUCTION 

This Commission staff working document accompanies the report on the implementation of the third 

Health Programme in 2015. The report highlights some of the key initiatives co-funded to further EU 

health policy and implement EU directives. This staff working document also showcases the results of 

measures co-funded under the second Health Programme, which ended in 2015: it provides a focus on 

actions that were co-funded in 2015 responding to the specific needs raised under the refugee crisis 

(CARE,  EUR-HUMAN,  SH-CAPAC,  8  NGOs  in  11  States).  It  further  includes  actions  that 

correspond  to  overarching  themes  (such  as  rare  diseases  and  pilot  European  Reference  Networks, 

tobacco  control,  health  work  force  and  patient  safety,  mental  health,  HIV/AIDS)  which  have  been 

included  in  successive  financing  decisions.  Lastly,  it  highlights  several  useful  figures  and  statistics, 

rolls  out  the  full  list  of  all  co-funded  initiatives  and  contracts  provided  from  the  third  Health 

Programme operating budget in 2015. 

Highlights of initiatives ending in the reporting year: examples of the programme’s results 

Several  initiatives  co-funded  under  the  second  Health  Programme  ended  in  2015  and  produced 

interesting results that were further taken up and built onto different levels of other actions. Several 

examples of actions that had significant outcomes are described below. More information about these 

and other projects and joint actions and their results can be found in the Health Programme Database 
managed by the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA)1. 

Please  note  that  this  Database  covers  actions  co-funded  under  the  EU  Public  Health  Programme, 

namely the second and third Health Programmes.  

Most importantly, the amended 2015 work programme called for the co-financing of actions related to 

"Support Member  States to  migratory  pressure  in their response to  health  related  challenges"  which 

covered Objective 1 and Objective 2 of the third Health Programme.  As mentioned in the main report 

(REPORT  FROM  THE  COMMISSION  TO  THE  EUROPEAN  PARLIAMENT  AND  THE 

COUNCIL  -  Implementation  of  the  third  Programme  of  Community  action  in  the  field  of  health  in 

2015)  four  projects  were  awarded  EU  co-funding  from  the  third  Health  Programme  and  one  direct 

grant was signed with IOM.  

1 http://ec.europa.eu/CHAFEA/health/index.html  

4 

 
 
 
                                                      
JOINT ACTIONS 

ORPHANET  

Background information 

ORPHANET is the world reference portal for information on rare diseases and orphan drugs, for all 

audiences, including patients, policy makers, healthcare professionals and the scientific community at 

large. It is coordinated by the French INSERM institute and brings together partners from 23 Member 

states (AT, BE, BG, CY, CZ, EE, FI, DE, GR, HU, IT, LT, LV, NL, PL, PT, RO, SK, SL, ES, SE, 

UK). From 2011 to 2015, the action received EU co-funding of EUR 3 500 000. 

Brief description 

ORPHANET’s  objective  was  (and  remains)  to  help  improve  the  diagnosis,  care  and  treatment  of 

patients with rare diseases. The Orphanet database is a strategic element in national policies for Rare 

diseases: its nomenclature and classification are the basis for codification of these diseases in national 

health information systems.  

ORPHANET  provides  a  single  hub  where  all  information  and  knowledge  is  collected,  reviewed, 

validated and disseminated back to the national health systems and all other stakeholders and actors: to 

the  health  professionals  to  improve  their  understanding  and  knowledge  of  these  diseases;  to  the 

researchers  and  academics,  to  develop  new  treatments  and  therapies,  to  the  policy  makers  at  local, 

regional, national and international levels to develop appropriate responses; and, more importantly, to 

the patients themselves. 

In  its  current  development  phase,  the  network  developed  tools  for  improving  the  validation  and 

publication of data collected by national teams. The action also focused on upgrading the quality of 

the database, easing its update and validation.  

Specific results 

Information  delivered  through  the  Orphanet  website,  is  accessed  more  than  35,000  times/day  from 

more than 200 countries, representing 1.3M sessions a month. Massive datasets are made available for 

free re-use by researchers, industry and policy-makers in machine-readable formats through Orphadata 

(approximately 14,000 downloads/month). 

5 

 
 
 
The  Orphanet  website  is  currently  available  in  8  languages  (English,  French,  Italian,  Spanish, 

Portuguese,  German,  Dutch  and  Polish),  but  the  textual  information  is  progressively  translated  in 

many more languages. 

Orphanews  has  a  multi-stakeholder  audience  (2017  data)  of  12’000  subscribers  for  the  English 

language version alone (more than 8’400 subscribers for the French edition and 5’600 for the Italian 

edition) 

Orphanet  provides  access  to  a  catalogue  of  expert  services  by  disease  in  35  countries  of  the  41-

countries  Orphanet  network,  such  as  centres  of  expertise,  laboratories  and  diagnostic  tests,  patient 

organisations, research projects and clinical trials, registries, biobanks and research infrastructures. 

The Orphanet encyclopaedia is intended to help professionals in their clinical practice, but patients and 

their relatives also benefit from it.  

Orphanet  disseminates  good  quality  articles  produced  by  other  stakeholders,  including  articles 

intended  to  lay  persons,  after  having  assessed  them  for  quality. The  high-quality  directory  of expert 

resources and patient organizations is of help both for health professionals and for patients, improving 

referrals and patient orientation. 

PROJECTS 

1.  EUReMS – European Register for Multiple Sclerosis – A tool to assess, 

compare  and  enhance  the  status  of  people  with  Multiple  Sclerosis 

throughout the EU  

Background information 

As  one  of  the  projects  of  the  health  promotion  strand,  the  European  Register  for  Multiple  Sclerosis 

(EUReMS) project ran from July 2011 until September 2014 with a co-funding of EUR 987.198,00. It 

involved a consortium of 12 partners from ten EU countries (BE, DE, ES, HR, IT, NO, PL, RO, SE, 

UK)  to  address  the  unmet  needs  of  people  living  with  Multiple  Sclerosis  (MS).  Further  to  its 

geographical  outreach,  the  action  also  brought  together  partners  from  different  sectors  such  as 

professional  societies  and  patient  organisations,  public  health  organisations,  research  and  academic 

organisations, ensuring that their unique perspectives contribute directly to the actions' results. 

6 

 
 
 
 
Brief description 

The project addressed the lack of comparative data at EU and national level on treatment and care for 

people with multiple sclerosis and was, thus, closely aligned with the European Commission’s efforts 

to fight health inequalities faced by European citizens. 

As a pioneer in this field, EUReMS identified and pooled MS-related data from different registries – 

hospitals,  professional  societies  and  research  centres  around  Europe  –  and  created  a  cross-border 

partnership for its safe and effective storage, analysis, interpretation and dissemination. It also proved 

that integration of data from different sources is possible: the establishment of a European Platform for 

systematic collection, exchange and analysis of longitudinal data on MS in Europe will eventually lead 

to a better assessment of the situation of people with MS and ultimately to better outcomes for those 

living with MS in Europe. 

Specific results 

The information gathered through EUReMS is being stored at/ managed by the Medical Centre of the 

University  Göttingen,  Germany,  while  dissemination  is  coordinated  by  the  EMSP  through  its 

Secretariat in Brussels. 

EUReMS  data already  enabled the  analysis  of:  costs and  resources  related  to  the  burden  of  disease; 

age and gender-specific disease trends; and use of disease-modifying drugs and their impact.  

This newly created data pool also proved that more and better data can drive policy improvements and 

provide  incentives  for  new  research,  by  opening  up  post-project  end  studies  on:  prevalence  and 

incidence  of  MS  in  Europe;  access  and  effectiveness  of  treatments;  quality  of  life  and  burden  of 

disease issues. 

2.  EPIRARE – European Platform for Rare Disease Registries 

Background information 

The project ran from April 2010 to October 2013 with an EU contribution of EUR 661 402. Under the 

leadership of the National Centre for Rare Diseases of the Italian Istituto Superiore di Sanitá (ISS) it 

involved partners from 8 countries (BE, BG, ES, FR, GR, IT, NL, UK). 

The project aimed to build wide ranging consensus among the scientific community and policy makers 

to  address  regulatory,  ethical  and  technical  issues  associated  with  the  registration  of  rare  diseases 

patients  and  to  elaborate  possible  policy  scenarios.  In  fine,  the  action  studied  the  feasibility  of 

7 

 
 
 
registration of a minimum data set common to all rare diseases, designed to inform policy-making; the 

conditions to admit  research-driven  disease  or treatment-specific  modules;  and  the  ways  to  ensure a 

sustainable data flow. Specific attention was given to the scenario of the creation of an EU platform 

for the collection of data on Rare diseases patients and their communication among qualified users.   

Brief description 

The project identified possible policy scenarios to enhance data collection in the area of rare diseases, 

defining the scope of such collection; the corresponding governance framework and possible options 

for  sustainability,  including  an  enabling  legal  framework.  To  do  so,  it  identified  all  the  existing 

registries, whether pharma centred or oriented towards wider public health aims; industry sponsored, 

academic, or publicly owned. 

The sustainability of EU Rare disease patients' registration was pursued by defining the aims and the 

scope  of  a  potential  common  EU  wide  platform  and  appropriate  governance  models.  Finally,  a 

common  data  set  was  developed,  consistent  with  a  public  health  approach,  while  attention  was  also 

given to the use of different data sets and the services which could potentially be made available based 

on the latter. The involvement of all relevant stakeholders was also ensured, considered instrumental 

to foster the implementation and sustainability of the recommendations made at the end of the action. 

Specific results 

The project prepared the ground for the collection of an agreed common set of data from rare diseases 

patients providing also rules to ensure data quality and data validation and improve as far as possible 

comparability of data among countries.  

The results of the action were taken up by the EU Committee of Experts on Rare Diseases (EUCERD) 

and have been instrumental in the collaboration agreement established between DG SANTE and the 

Joint Research Centre (JRC), tasked with carrying forward the efforts for an EU-wide RD registration 
effort. The results of the action are available on the project website2 as well as in CHAFEA's Health 
programme Database3. 

2 http://www.epirare.eu/del.html  

3 https://webgate.ec.europa.eu/CHAFEA_pdb/health/projects  

8 

 
 
 
                                                      
3.  EURO-WABB  –  EU  Rare  Diseases  Registry  for  Wolfram  syndrome, 

Alström  syndrome,  Bardet-Biedl  syndrome  and  other  rare  diabetes 

syndromes  

Background information 

The project ran from January 2011 to June 2014 with an EU contribution of EUR 900 000. It involved 

partners from 6 countries (EE, ES, FR, IT, PL, UK) and supported efficient diagnosis, treatment, and 

research for the overlapping rare genetic diseases Wolfram, Alström and Bardet Biedl syndromes and 

other rarer diabetes syndromes in Europe. This was achieved by implementing an EU registry for Rare 

Diabetes Syndromes, containing clinical, genetic diagnostic and outcome data.  

Brief description 

The purpose of the registry was: 1) to establish the natural history of Rare Diabetes Syndromes (their 

characteristics,  management  and  outcomes);  2)  to  assess  clinical  effectiveness  of  management  and 

quality of care; 3) to provide an inventory of patients for recruitment to intervention studies; and last 

but not least 4) to establish genotype-phenotype correlations.  

The  project  used  validated,  quantitative  questionnaires  and  focus  groups  of  health  professionals,  to 

scope  the  requirements  of  centres  for  submitting  data  to  the  Registry.  Further,  it  developed  a 

consensus  on  a  core  dataset  for  the  Registry,  then  developed  a  multifunctional  web  based  Registry 

with user friendly browser-based access. To achieve high usage of the registry, this was linked to rapid 
genetic testing4; and to up to date, accurate information, and education material. 

Specific results 

The  project  led  to  a  step  change  in  the  volume  and  quality  of  clinical  research  in    Rare  Diabetes 

Syndromes  diseases  by  enabling  the  following  important  outcomes:  equal  access  to  genetic  testing, 

education  of  health  professionals,  and  empowerment  of  patients  (Council  Recommendation  on  rare 

diseases);  adequate  inventorying  of    Rare  Diabetes  Syndromes  diseases;  supporting  research; 

development  of  centres  of  expertise;  gathering  expertise  at  European  level;  empowering  patient 

4 A Rare Diabetes Syndromes microarray capable of identifying up to 600 different mutations was created and 
used across all participating centres 

9 

 
 
 
                                                      
organizations  as  partners;  developing  sustainability  by  underpinning  a  future  European  Reference 

Network  for    Rare  Diabetes  Syndromes  diseases;  supporting  the  High  Level  Pharmaceutical  Forum 

Recommendations  (2008);  and  supporting  improvement  in  health  outcomes  which  is  a  key  Lisbon 

strategy indicator. 

The registry is also transferable to scientists exploring the mechanisms underlying common diabetes 

and  obesity.  This  will  enable  a  change  the  understanding  of  these  rare  diseases  through  increased 

knowledge  of  the  natural  history  and  genotype  phenotype  relations  informing  prognosis.  Rare 

Diabetes  Syndromes  diseases  will  have  increased  visibility  to  the  research  and  health  provider 
communities  through  Orphanet5  and  EURORDIS.  A  change  in  clinical  effectiveness  of  services  for 

Rare Diabetes Syndromes patients can also be expected: the registry will provide data for assessing the 

clinical  effectiveness  and  cost-effectiveness  of  standard  care  and  new  interventions  in  a  real-world 

setting.  This,  in  turn,  would  lead  to  improvements  in  quality  of  care.  The  Registry  is  expected  to 

identify disparities between health care outcomes and provide evidence for health service providers for 

improvements.  

The results are available on the project website6 as well as in CHAFEA's Health Programme 
Database7. 

4.  EUREGENAS – European Regions enforcing Actions against Suicide 

Background information 

A health promotion action, the EUREGENAS project ran from January 2012 to December 2014 with a 

co-funding of EUR 750 000. It involved 19 partners in 10 EU countries (BE, DE, ES, FI, IT, PT, RO, 

SE, SI, and UK). 

The  EUREGENAS  project  contributed  to  the  prevention  of  "suicidality"  (suicidal  ideation,  suicide 

attempts and suicide) in Europe through the development and implementation of innovative strategies 

5 https://www.orpha.net/consor/cgi-bin/index.php  

6 http://www.euro-wabb.org/en/   

7 https://webgate.ec.europa.eu/CHAFEA_pdb/health/projects  

10 

 
 
 
 
 
                                                      
for suicide prevention at regional level that can be of use as examples of good practice across other 

regions of the European Union. 

Brief description 

The action has been implemented following the 5 following phases: 

 

Identifying  and  cataloguing  good  practices  of  existing  actions  and  strategies  on  suicide 

prevention 

  Carrying out a stakeholders’ needs analysis 

  Developing  and  disseminating  guidelines  and  toolkits  on  suicide  prevention  and 

awareness raising strategies 

  Developing  the  technical  specifications  for  an  integrated  model  for  e-mental  healthcare 

oriented at suicide prevention 

 

Improving  knowledge  and  capabilities  among  local  and  regional  professionals  (i.e. 

psychologists, psychiatrists, general practitioners) 

Specific results 

The action involved a range of professional categories, including key target groups outside the medical 

profession (e.g. journalists, teachers, stakeholders from the workplace), as evidence points to the role 

which they can play in effective prevention methods. With their help it delivered a series of innovative 

tools on several levels; they include a "Suicide prevention toolkit for Media Professionals, Workplace 

and  Schools";  a  "Training  module  for  General  Practitioners";  and  a  "Toolbox  for  facilitators  of 

survivor support groups".  

Acknowledging  the  potential  of  Information  and  Communication  Technologies    in  reaching  the 

younger  population,  especially  vulnerable  to  the  "idealisation"  of  suicide,  the  action  also  developed 

tools  addressing  both  the  ethical  and  technical  dimensions  of    Information  and  Communication 

Technologies  enabled  prevention  (eg:  Ethical  Guidelines  for  Technology-Based  Suicide  Prevention 

Programmes). 

The deliverables of the action are highly innovative and have attracted significant interest from several 

other  EU 

regions; 

and 

they 

are 

accessible 

in 

the 

project's 

online 

library 

(http://www.euregenas.eu/publications/). 

11 

 
 
 
For further information, visit CHAFEA's Health Programme Database8. 

5.  SIALON II – Capacity building in combining targeted prevention with 

meaningful HIV surveillance among MSM 

Background information 

The health security project SIALON II project ran from November 2011 to January 2015 with a co-

funding of EUR 989 960, 00. It brought together 28 partners representing Public Health Institutions, 

Academia and NGOs from 10 European countries (BE, BG, ES, DE, IT, LT, PL, PT, RO, SK) with 

the overall objective to carry out and promote combined and targeted prevention complemented by a 

meaningful surveillance among men who have sex with men .   

Brief description 

HIV/AIDS  is  recognised  as  a  major  cross  border  health  threat.  Recent  data  painting  an  alarming 

picture  of increased  prevalence, especially  in  the  context  of the financial  crisis  and  the  reduction  of 

national prevention budgets to which it has resulted in. The HIV/AIDS surveillance 2014 report by the 

European Centre for Disease Control (ECDC), shows that the number of HIV diagnoses among men 

who have sex with mencontinues to increase in the EU/EEA, representing the higher proportion (42%) 

of new HIV diagnoses 

To  better  understand  the  underlying  causes  of  this  situation,  Sialon  II  worked  on  generating 

comparable  data  on  behavioural  and  epidemiological  indicators  for  men  who  have  sex  with  men 

communities in 13 different EU Member states.  

The  action  applied  new  methods  building  an  extensive  prevention  and  promotion  campaign,  and 

resulting  in  extensive  voluntary  community  testing.  The  contribution  of  the  primary  target  group 

enabled  the  use  of  high  impact  methodologies,  such  as  oral  fluid  and  serum  testing  methods  for 

HIV/STI surveillance. It also resulted in the expansion and consolidation of a very extensive European 

network  used  for  the  statistical  analysis  and  data  comparison  based  on  a  commonly  developed 

framework. 

Specific results 

8 https://webgate.ec.europa.eu/CHAFEA_pdb/health/projects  

12 

 
 
 
                                                      
The project became an international reference initiative, presented by UNAIDS, WHO and ECDC as a 

model for bio-behavioural surveillance and prevention among men who have sex with men.  

The SIALON II results showcased the importance of the active involvement of stakeholders: the men 

who have sex with men civil society organisations were directly implicated on the survey design; the 

performance  of  the  data  collection;  the  review  of  the  survey  report,  including  the  creation  of  city 

profiles; and the execution of prevention activities, based on community involvement and peer to peer 

education. 

Further to the quantitative data on HIV prevalence in general  - and new infections in particular - the 

survey  main  findings  were  summarised  in  a  policy  brief  -  City  Profile  -  focusing  on  the  main 

prevention implications at local level. 

Further information is available on the Sialon II website9.  

6.  Special  Call:  Support  Member  States  to  migratory  pressure  in  their 

response to health related challenges 

In urgent response to the Call to "Support Member States to migratory pressure in their response to 

health related challenges", and as mentioned in the main report, the highlight of 2015 was the amended 

annual  work  programme  2015  that  added  another  Call.  In  turn,  four  projects  were  awarded  EU  co-

funding  from  the  third  Health  Programme  and  one  direct  grant  was  signed  with  the  International 

Organisation for Migration (IOM). The actions' aims were to support Member States under particular 

migratory  pressure  in  their  response  to  health  related  challenges  and  were  implemented  throughout 

2016 as an immediate response: 8 NGOs in 11 States, SH-CAPAC, EUR-HUMAN, and CARE; and 

one  direct  grant  with  IOM  described  below  under  the  section  on  Direct  Grants  with  International 

Organisations. 

7.  8 NGOs in 11 States 

Background information 

The  Project  8  NGOs  in  11  States  is  a  project  where  8  NGOs  came  together  to  support  the  health 

authorities of 11 EU Member States (BE, BG, DE, EL, ES, FR, HR, IT, NO, SE, SI). Led by Médecins 

9 http://www.sialon.eu/en/  

13 

 
 
 
                                                      
du  Monde10,  it  supported  the  health  authorities  of  the  participating  Member  States  in  providing 

individual health assessments via the use of an agreed EU health booklet (used also by DG HOME) 

that could identify specific health issues and prevent health threats. 

Brief description 

The project focused on implementing flexible and adaptive mechanisms such as mobile surveillance 

and response health units to identify arrival and transit locations to provide continued assessment and 

meeting  of  geographically  rapidly  changing  needs.  Further,  it  assessed  general  health  needs  and 

emerging needs and responded to urgent health issues.  

The 8 NGOs thus ensured the reduction of cross-border health threats, carried out health assessments 

of individuals (for mental and physical health), referred to adequate and accessible primary healthcare 

(including vaccination), informed on migrants' rights to access healthcare. The 8 NGOs also improved 

appropriate response and inform health authorities by sharing and discussing experiences and lessons 

learned  with  local  and  national  health  authorities  and  with  European  policy  makers;  ensured  that 

monitoring of health needs and access to health for migrants were monitored and core indicator data 

collection.  Last  but  not  least,  the  8  NGOs  built  within  its  team  capacities  in  responding  to  urgent 

migrants’ health needs through active European coordination and mutual learning mechanisms. 

Specific results 

The action deployed 12 mobile units in 11 participating countries; 2012 contacts were carried out with 

other  actors  in  order  to  map  the  needs;  the  mobile  units  accessed  699  detected  spots  within  the 

identified areas of intervention; and a total of 2459 urgent individual health assessments were carried 

out with newly arrived migrants.  

The 8 NGOS performed health assessments in 11 participating countries:  49 707 physical and 1 775 

mental health assessments; and 4 811 social consultations were also carried out.  

There were 2 459 urgent individual health assessments with newly arrived migrants, 3 270 referrals to 

public  health  care  providers,  26  601 leaflets  disseminated,  250  calls to the  hotline,  and  443  migrant 

10  Médecins  du  Monde  also  received  EU  co-funding  under  the  health  programme  through  the  award  of  an 
operating grant, covering the years 2015-2017, in support of the  European network to reduce vulnerabilities in 
health, bringing together NGOs and academic partners from 17 EU Member States and 2 EFTA/EEA countries. 

14 

 
 
 
   
                                                      
group sessions (info/education). The 8 NGOs also involved in information and awareness initiatives 

and  carried  out  992  meetings  with  health  authorities  and  other  local  actors  where  494  health 

professionals participated in the sessions.    

Publications and further information can be found on the website of Médecins du Monde11.  

8.  SH-CAPAC  –  Supporting  health  coordination,  assessments,  planning, 

access to health care and capacity building in Member States 

Background information 

Project  SH-CAPAC – "Supporting health coordination, assessments, planning, access to health care 

and capacity building in Member States under particular migratory pressure", led by the Andalusian 

School of Public Health,  brought together partners from 7 countries (BE, DK, ES, IT, NL,PL, SK). to 

support  MS  in  the  establishment  or  strengthening  of  a  health  sector  coordination  mechanism, 

improving  capacities  and  skills  of  health  professionals  and  ensuring  adequate  control  of  potential 

health  threats  for  a  coherent  and  consolidated  national  and  cross-country  response  to  the  potential 

impact of the extraordinary influx of refugees, asylum seekers and other migrant populations.  

Brief description 

The action firstly mapped the response of the participating MS to the health needs of refugees, asylum 

seekers and other migrants. Country Profiles were prepared for each of the 19 target countries of the 

project with analyses of major trends: countries of first arrival and transit countries (BG, HR, EL, HU, 

IT,  RO,  SK,  SI),  traditional  destination  countries  (AT,  BE,  DK,  FR,  DE,  MT,  SE,  NL),  new 

destination countries (PT, PL, ES). Further, SH-CAPAC supported:  

  The  development  of  action  plans  for  implementing  a  public  health  response  and  for 

reinforcing their health systems  

  The promotion and assurance of access of the refugee, asylum seekers and other migrants 

populations  to  health  care  and  public  health  interventions  through  the  development  and 

dissemination of a resource package to reorient local strategies and plans 

  The building of national capacity through training health workers 

11 http://www.medecinsdumonde.org/fr/populations/migrants-deplaces   

15 

 
 
 
                                                      
  The analysis of health challenges and unmet health needs 

Specific results 

The  results  were  achieved  through  the  development  of  practical  materials,  among  others:  the 

Coordination Framework; Guide for Assessment of Health Needs and Health Protection Resources; 

Guidelines  for the  Development  of  Action  Plans  for  Implementing  a  Public  Health  Response  and  to 

strengthen  Country’s  Health  Systems  to  address  the  needs  posed  by  the  influx  of  refugees,  asylum 

seekers and other migrants. 

Aimed  at  helping  relevant  stakeholders  in  target  Member  States  to  develop  action  plans  and 

contingency  plans  to  address  the  health  needs  posed  by  the  influx  of  refugees,  asylum  seekers  and 

other  migrants.  SH-CAPAC  also  engaged  in  6  country  support  missions  to  BG,  GR,  ES,  SK  to 

introduce,  disseminate  and  discuss  the  frameworks,  methodologies  and  tools  to  further  explore  the 

possibilities for improving coordination and coherence in the response. 

Publications and further information are available on the project's website12.  

9.  EUR-HUMAN – European Refugees – Human Movement and Advisory 

Network  

Background information 

EUR-HUMAN  was  led  by  the  University  of  Crete  and  involved  11  partners  from  8  countries.  The 

project  enhanced  the  capacity  of  EU  MS  accepting  migrants  and  refugees  via  establishment  of 

guidelines,  guidance training  and  health  promotion material  and  establishing  protocols  and tools  for 

assessment  of  local  resources  available.  This  initiative  focused  on  addressing  both  the  early  arrival 

period and longer-term settlement of refugees in European host countries.  

12 http://www.easp.es/sh-capac/  

16 

 
 
 
 
 
 
 
                                                      
Brief description  

The  project  focused  on  defining,  designing  and  evaluating  interventions  aimed  at  developing 

integrated human-centred interventions for the provision of primary health care to refugees and other 

migrants.  

Such interventions included, amongst others, the development of tools and guiding documents for the 

provision  of  continuous  primary  health  care  (including  emotional,  psychosocial  and  physical 

wellbeing assessments), from the arrival toward any relocation and final destinations. 

In  coordination  with  national,  regional  and  local  stakeholders  engaged  in  providing  assistance  to 

migrants  and  their  families,  EUR-HUMAN  targeted  newly  arrived  refugees  and  migrants,  primary 

health care professionals and social service providers across different settings. 

Specific results 

The project was grounded on a holistic and person-centred Model of Continuity of Care aimed at the 

provision  of  appropriate  acute  and  PHC,  as  well  as  social  service  support  to  refugees  and  other 

migrants.  Applying  a  Participatory  Learning  and  Action  research  methodology,  the  health  needs, 

social  problems  and  barriers  to  access  primary  health  care  were  identified  for  refugees  and  other 

migrants. 

By  developing  an  Appraisal  Tool  for  Optimizing  Migrant  Health  Care’  (ATOMiC),  a  practical 

guidance for improving quality and access to PHC services was specifically made then available for 

primary health care professionals, health managers and policy makers. 

A  Model  of  continuity  of  psychosocial  refugee  care  was  also  developed  to  address  mental  health 

aspects  related  to  migration.  A  Protocol  for  early  identification  of  highly  traumatized  refugees  and 

other  migrants  was  developed  based  on  a  step  wise  model  of  care  consisting  of  triage,  screening, 

immediate  assistance  based  on  Psychological  First  Aid  principles,  and  referral  procedure  for  full 

mental  health  assessment  and  care  as  needed.  It  included  guidelines  and  procedures  for  rapid 

assessment of mental health needs and psychosocial status. Models, protocols and tools produced by 

the  project  were  finally  piloted  and  tested  against  effectiveness  in  participating  countries  during  an 

Intervention  Training  Programme  made  available  also  on-line  (e-training).  It  consists  of  eight 

different  modules  for  primary  health  care  providers, translated  in  seven  EU  languages  (plus  Arabic) 

and adapted to country-specific settings (early hosting and first care centres, transit centres and centres 

for asylum seekers). 

17 

 
 
 
More  results  are  available  on  the  project  website13  as  well  as  in  CHAFEA's  Health  Programme 
Database14. 

10. CARE - Common Action for Refugees and other migrants’ health  

Background information  

CARE  -  Common  Action  for  Refugees  and  other  migrants’  health  was  led  by  the  Italian  National 

Institute  for  Health  Migration  and  Poverty  and  included  a  broad  and  highly  skilled  mix  of  public 

health authorities and civil society organisations from five European Countries (GR, HR, IT, MT, SL), 

all with scientific, policy and public health background . The main focus of the CARE project was to 

promote and sustain the good health of migrants and populations in MS experiencing strong migrant 

pressure.  

Brief description  

The  project  focused  on  the  collection  of  health  data  for  syndromic  surveillance  in  hotspot/reception 

centres and establish digital health records. Further, the project also monitored communicable diseases 

by  ensuring  rapid  detection  of  disease  outbreaks,  while  also  assessing  the  current  policy  in 

vaccination, and provided information on endemic and current epidemic diseases in the countries of 

origin.  Furthermore,  the  project  tracked  and  monitored  health  status  of  migrants/refugees  at  the 

moment of their arrival based on advanced technology (smart devices and tags).  

The  CARE  project  also  engaged  in  raising  knowledge  and  awareness  actions  towards  the  general 

public with regard to “true” and “false” health topics about migrants and refugees and among others 

also promoted migrants health literacy with emphasis on the right to access public health care services 

in MSs aiming to facilitate delivery of services to migrants according to their age. Last but not least it 

supported  national/regional  planning  and  the  role  of  civil  society  organisations  to  support  the 

development of integrated public health plans, relevant to migrant and refugee populations. 

Specific results 

The project ensured the performance of over 11 000 medical examinations in IT. It also developed and 

tested of a Protocol for age assessment into the hotspots through a holistic approach with assessment 

13 http://eur-human.uoc.gr/about/  

14 https://webgate.ec.europa.eu/CHAFEA_pdb/health/projects  

18 

 
 
 
                                                      
of 75 children in IT and 103 in GR. Furthermore, it developed the following: syndrome surveillance 

system,  web-based  platform,  survey  on  immunization  policies  targeting  newly  arrived  migrants  in 

different EU countries;  travel medicine information service model on endemic and epidemic diseases 

in the migrants' countries of origin and transit using digital disease detection (13 dispatches produced); 

the customization and production of an electronic health record; created residential database (2 in IT; 4 

in GR) and inventory of all the existing materials, practices and trainings in participating countries and 

many  other  very  practical  materials  (for  example,  informative  booklets  and  leaflets  in  different 

languages  addressing  health  literacy  for  migrants  and  misconceptions  about  migrants  for  general 

population). In addition, the project helped identify good practices and prepared recommendations for 

public  health  policy  regarding  migrant  and  refugee  populations  and  the  role  of  civil  society 

organisations (IT, GR and SI). 

The  results  are  available  on  the  project  website15  as  well  as  in  CHAFEA's  Health  Programme 
Database16. 

15 http://careformigrants.eu/the-project/  

16 https://webgate.ec.europa.eu/CHAFEA_pdb/health/projects  

19 

 
 
 
 
 
 
                                                      
OPERATING GRANTS 

2015  was  the  first  year  that  CHAFEA  has  implemented  the  so-called  Framework  Partnership 

Agreements as a means of providing a new framework of long-term cooperation and financial support 

to Non-Governmental Organisations active in any of the areas of the Health programme.  

Such an approach was considered as an adapted response to the needs of such organisations: this type 

of agreement helps establish a partnership structure for important actors of civil society at EU level; 

secondly,  it  offers  a  clearer  financial  perspective  for  the  non-governmental  bodies/  networks;  and 

thirdly, it provides more stability and efficiency gains for all involved.  

In  total  14    framework  partnership  agreements  were  signed  with  successful  applicant  organisations 

covering the years 2015-2018, and resulting in financial support being awarded to through the linked 

specific grant agreements to cover their annual recurrent operational expenses for the financial years 
2015-201817.  

Ten framework partnership agreements and their Specific grant agreements responded to the Objective 

1  of  the  third  Health  Programme:  "Promote  health,  prevent  diseases  and  foster  supportive 

environments for healthy lifestyles taking into account the 'health in all policies' principle", whereas 

another  three,  responded  to  Objective  4:  "Facilitate access to better  and  safer healthcare for  Union 

citizens". 

17 One of the 14 applicant organisations awarded a Framework partnership agreement became bankrupt in 2015. 

20 

 
 
 
 
 
 
 
 
 
 
 
 
                                                      
Table  1:  List  of  applicant  organisations  having  been  awarded  an  Framework  partnership 
agreement and subsequent Specific grant agreement 

Organisation 

Alzheimer Europe 

World Obesity Federation 

Smoke Free Partnership 

Results Education 

European Network for Smoking Prevention 

Deutsche AIDS-HILFE EV 

SO Europe Eurasia Foundation 

Association européenne des Ligues contre le Cancer 

European Public Health Alliance 

Association Médecins du Monde 

Stitching Health Action International 

Forum Européen des Patients (FPE) 

European Organisation For Rare Diseases Association 

1.  EURORDIS FY2015 -2018 European Organisation for Rare Diseases 

Background information 

The operating  grant in the field of rare diseases EURORDIS ran from 2015 through to 2017 with a 

maximum EU co-funding of EUR 2 354 422.  

21 

 
 
 
 
EURORDIS is a patient-driven alliance of Patient Organisations supporting the active involvement of 

Rare  Disease  patients,  families  and  their  representatives  –  as  the  main  concerned  segment  of  civil 

society - in the definition of priorities and implementation of actions on rare diseases at national, EU 

and international levels.  

Brief description 

A key objective of EURORDIS is to consolidate the Rare disease patient’s community and strengthen 

the patients’ voice.  

Bringing together more than 700 patient organisations and speaking as a single voice for them creates 

a unique capacity to reach out, a capacity that no single patient organisation could attain on its own. In 

addition,  a  significant  amount  of  resources  go  into  capacity  building  activities,  empowering  Rare 

disease patients as advocates and volunteers.  

Another of the main focus areas of EURORDIS is to improve access to high quality health and social 

care  services  for  rare  diseases  patients,  including  diagnosis,  treatment,  or  interventions  improving 

quality  of  life.  To  do  so,  EURORDIS  has  actively  represented  patients  in  all  initiatives  relevant  to 

these areas, including the active participation in the committees of the European Medicines Agency; 

the collaboration on HTA; the implementation of the EU pharmacovigilance legislation; or the setting 

up of European Reference Networks (ERNs).  

It has thus established itself as a key actor and recognized and respected partner by the academic and 

research communities, governments and public health authorities, as well as EU institutions. 

Specific results 

The operating grant has enabled among other activities: 

  The consolidation of the rare disease patient community with: an increase of the EURORDIS 

Membership base; the public awareness campaigns and the Rare Disease Day; the update and 

maintenance  of  the  EURORDIS  website;  the  dissemination  of  electronic  newsletters;  the 

management  of  EURORDIS  social  media;  the  production  and  dissemination  of  reference 

documents. EURORDIS continued to provide networking and capacity building opportunities 
to  its  members  in  28  EU  countries  in  2017.  RareConnect18,  the  EURORDIS  online  patient 

18 https://www.rareconnect.org/en  

22 

 
 
 
                                                      
communities  platform  continued  to  grow  reaching  over  26  000  registered  users  &  90 

communities.    By  the  end  of  2017  EURORDIS  increased  the  number  of  the      patient 

organisations in its contact database to 2 712. 

  The  engagement  of  rare  patient  representatives  into  the  effective  implementation  and 

monitoring  of  legislation  and  strategies  through  support  of  patient  involvement  in  

Commission  Expert  Groups  such  as  the    EU  Committee  of  Experts  on  Rare  Diseases;    the 

European Medicines Agency’s Committees  and activities; promotion of access to medicines.  

  The capacity building and empowerment of EURORDIS members and volunteers through: the 

annual  EURORDIS  membership  meeting  which  includes  capacity  building  workshops  for 

members; provision of support to the Council of the European Network of National Alliances 

and  the  Council  of  European  Federations;  the  EURORDIS  Summer  School  in  drug 

development,  clinical  trials,  regulatory  affairs  which  reached  a  significant  number  of 

attendance with 62 participants representing 27 countries and 43 diseases. The Operating grant 

has also enabled EURORDIS to identify, involve and support a growing volunteer base (from 

132 in 2014 to 428 in 2017). 

23 

 
 
 
 
 
 
DIRECT GRANTS WITH INTERNATIONAL ORGANISATIONS 

The  AWP  2015  under  Actions  under  Objective  1,  Objective  3  and  Objective  4  committed  several 

direct grants with the OECD. This report highlights three such actions that are overarching across the 

second year of the third Health Programme.  

In  addition,  IOM's  RE-HEALTH  direct  grant  is  also  presented  below  to  illustrate  the  response  to 

migratory pressure and responding to Objective 1 and Objective 2 of the third Health Programme. This 

direct grant complemented the 4 co-funded projects in this field of work as described above (under the 

section PROJECTS).  

1.  OECD-PS  –  DATA  AND  ANALYSIS  OF  DATA  ON  PATIENT 

SAFETY  WITHIN  THE  OECD  HEALTH  CARE  QUALITY 

INDICATORS PROJECT 

Background information 

This action, falling under Objective 4 of the EU Health Programme on "Facilitating access to better 

and  safer  healthcare  for  Union  citizens"  and  more  specifically  under  "Data  and  analysis  of  data  on 

patient  safety"  and  within the  OECD  Health  Care  Quality  Indicators  Project.  OECD-PS  received an 

EU co-funding of EUR 150.000,00. 

The policy importance of the OECD’s indicator development work was noted in December 2014 by 

the  Council  of  the  European  Union  and  subsequently  by  the  European  Parliament  in  making  its 

resolution on safer healthcare in Europe in May 2015. 

In  the  resolution,  the  Parliament  welcomed  the  work  co-financed  by  the  EU  and  performed  by  the 

OECD  on  comparable  patient safety indicators  and  called  on  EU Member  States  to  implement such 

indicators with a view to assessing patient safety. The OECD and the EC  thus agreed to support the 

on-going development and use of international patient safety indicators.  

The  general  objective  of  this  direct  grant  was  to  improve  the  ‘action  ability’  of  the  OECD  patient 

safety indicators in EU Member States and OECD member countries, including a focus on expanding 

the scope, uptake and use of these indicators.  

24 

 
 
 
 
 
Brief description 

The OECD established a set of international patient safety indicators and has regularly collected data 

from member states over the past decade. Over this period the OECD undertook additional research 

and  methodological  development  work  on  these  indicators  to  improve  their  robustness  for 

international comparison. To achieve its general objective, the action targeted the following specific 

objectives:  

 

It  provided  understanding  on  the  current  use  of  patient  safety  indicators  for  quality 

improvement  and  performance  assessment  across  EU  Member  States  and  OECD  member 

countries, including the key challenges being faced by countries currently not implementing 

the patient safety indicators and the key barriers and enablers to further use of the indicators in 

countries with existing programmes  

 

It  used  the    collected  "intelligence"  to  develop  future  strategies  for  broader  implementation 

and more purposeful use of the indicators in improving quality of care in EU Member States 

and OECD member countries;  

 

It  continued  to  develop  the  methodology  of  the  existing  safety  indicators  to  improve  their 

utility and amenability for use by EU Member States and OECD member countries.  

 

It built support for the adoption of additional indicators that broadened the scope of services 

and/or perspectives on patient safety.  

Specific results 

The present direct grant focused on strengthening the uptake and use of the following OECD Health 

Care Quality Indicators and their ‘action ability’ for policy makers: 

-  Retained surgical item or unretrieved device fragment  

-  Postoperative pulmonary embolism – hip and knee replacement discharges  

-  Postoperative DVT – hip and knee replacement discharges  

-  Postoperative sepsis - abdominal discharges  

-  Postoperative wound dehiscence – abdominal discharges  

-  Obstetric trauma vaginal delivery with instrument  

-  Obstetric trauma vaginal delivery without instrument  

-  Polypharmacy among elderly  

25 

 
 
 
-  Overall volume of opioids prescribed  

-  Death Rate among Surgical Inpatients with Serious Treatable Complications  

2.  OECD-HWF  –  Feasibility  study  for  an  international  survey  of  health 

workers’ skills 

Background information 

Committed  under  the  AWP  2015's  call  reference  on  Health  Work  Force,  the  study  was  carried  out 

between September 2016 and August 2017 and received a co-funding of EUR 150 000,00, building on 

the  findings  of  the  previous  direct  grant  agreement  "20135201  OECD:  Overview  of  education  and 

training programmes for health professionals in the EU" which included an analysis of recent changes 

in education and training capacities in the EU and an assessment of skills use and skills mismatch in 

the health sector.  

Brief description 

Previously  collected  data  pointed  to  significant  levels  of  skills  mismatch,  while  no  data  source 

provided a sufficient sample size to analyse in depth the level of skills mismatch of different types of 

health professionals in a way that would allow for robust comparisons between different countries..  

The present study explored the feasibility of carrying out a sector-specific survey of the skills of health 

professionals.  For  this,  it  reviewed  the  status  of  existing  surveys  that  measure  health  professional 

skills,  identified  gaps  where  more  attention  and  resources  are  needed  to  generate  policy-relevant 

evidence  on  skills  requirements,  skills  use  and  skills  mismatch  in  healthcare  settings;  and  proposed 

feasible approaches to develop and implement skills assessment surveys.  

Specific results 

The main finding concluded that increasingly, health care demands adaptive problem-solving skills to 

respond  to  complex  and  non-routine  patient  care  issues,  as  well  as  complex,  multi-disciplinary  and 

frequently  stressful  working  environments.  In  the  coming  years,  countries  will  need  resilient  and 

flexible health workers who are armed not only with technical and clinical skills, but with cognitive, 

self-awareness  and  social  skills  that  will  enable  them  to  monitor  and  assess  the  situation,  make 

decisions, take a leadership role, and communicate and co-ordinate their actions within a team in order 

26 

 
 
 
 
to  achieve  high  levels  of  patient  safety  and  efficiency  as  well  as  assure  their  own  safety  and  job 

satisfaction. 

The main outputs included the mapping of data needs with existing data sources to identify data gaps, 

the  identification  of  possible  options  concerning  the  scope,  content  and  design  of  a  health-specific 

skills survey as well as possible next steps to move towards its implementation. 

3.  OECD-EOP – Economics of Prevention  

Background information 

Committed under the AWP 2015, the OECD EOP project ran from January 2017 to December 2018 
with a maximum co-funding of EUR 600 000.  

Brief description 

The  general  objective  of  this  project  was  to  assess  the  positive  and  negative  economic  impacts  of 

obesity  and  harmful  alcohol  use  in  terms  of  health  care  expenditures,  other  public  and  private 

expenditures, and broader economic costs. The geographical scope of the project included European 

Union  Member  States  as  well  as  other  OECD  member  countries,  although  the  Action’s  analytical 

framework  was  designed to  be  more  widely  applicable,  both  geographically  and  to  other risk  factor 

and disease areas (e.g. tobacco use; environmental risk factors; etc.). 

Central to the project were five major components: (1) the review of existing models and conceptual 

frameworks  used  to  estimate  the  economic  impacts  of  obesity,  harmful  alcohol  use  and  associated 

diseases; (2) the empirical estimation of economic impacts for European Countries in terms of health 

care costs; other direct consequences; labour market outcomes; economic impacts of welfare benefits; 

morbidity  and  mortality  costs;  (3)  the  assessment  of  impacts  on  human  capital  and  educational 

outcomes by linking school performance with obesity, physical activity and alcohol use, based on the 

HBSC  (Health  Behaviour  in  School-aged  Children)  survey;  (4)  the  assessment  of  the  potential  of 

selected public health policies to mitigate the economic impacts of obesity and harmful alcohol use, 

based  on  a  micro  simulation  model  currently  being  developed  by  the  OECD;  and  (5)  Production  of 

country  profiles  in  which  key  country-specific  data  and  findings  for  individual  countries  will  be 

collated and summarised in a standardised format. 

27 

 
 
 
 
 
Specific results 

The  project  established  a  model  to  evaluate  the  burden  of  Alcohol  and  BMI  and  the  impact  of 

innovative  policy  options.  The  novel  OECD  micro  simulation  platform  is  designed  to  model  the 

impacts  of  behavioural  and  metabolic  risk  factors  on  chronic  diseases  and  longevity,  as  well  as  the 

extent to which specific policies can modify these impacts. The model created synthetic life histories 

from birth to death. Quantitative estimated of the future global burden of chronic non-communicable 

diseases (NCDs) in the EU and policy impact (2016-2050) can be simulated. 

There has been growing interest and support of these results by national health policy makers, as well 

as  ministries  of  finance.  This  work  directly  supports  higher  government  decision  making,  by 

addressing (and modelling) economic consequences when trading-off various prevention and related 
policies. For further information, please visit OECD's website19.   

4.  IOM  -  RE-HEALTH  -  Support  Member  States  under  particular  migratory 

pressure in their response to health related challenges 

Background information 

The one year direct grant agreement with the acronym Re-HEALTH: Support Member States 

under  particular  migratory  pressure  in  their  response  to  health  related  challenges  was 
submitted by IOM20 Regional Office for Europe. This action supports the implementation of 

key  Commission  Strategies  Actions  under  thematic  priority  "Support  Member  States  under 

particular migratory pressure in their response to health related challenges".   

Brief description 

The aim of the action was to provide support to EU Member States under migratory pressure 

to  address  the  health  related  issues  of  arriving  migrants  while  preventing  and  addressing 

possible  communicable  diseases  and  cross-border  health  events  through  strengthening 

19 https://www.oecd.org/fr/sante/economics-of-prevention.htm 

20 The financial decision implementing Work Programme 2015 (COM/2015/C/ 3594) and its amendment 
(COM2015/C 7414) identifies IOM as the recipient for this direct grant agreement and this in accordance 
with Article 190 (1)(f) of Delegated Regulation (EU) N° 1268/2012.  

28 

 
 
 
                                                      
 
national  and  cross-border  disease  surveillance  and  response  capacities,  in  particular  at  the 

designated hotspots and in the key areas of reception of refugees and other migrants. 

Specific results 

RE-HEALTH work resulted in  the following 1)  establishing links between the hotspots  and 

the health systems; 2) making use of the established handbook to check the health status and 

needs  of  the  arriving  refugees  and  other  migrants,  to  ensure  that  health  assessments  and 

preventive  measures  are  provided  (incl.  vaccinations),  3)  taking  into  account  the  needs  of 

children  and  other  vulnerable  groups;  and  4)  ensuring  that  data  initially  collected  in  the 

handbook are kept in a database in order to be available at the destination country.  

29 

 
 
 
 
 
CALLS FOR TENDERS 

1.  SERVICE  CONTRACT:  Life  Table  Analysis:  health  system  cost 

effectiveness assessments across Europe  

Objective  

The objective of the contract was to standardise the methodology used for carrying out health-system 

cost-effectiveness assessments in the EU-27 Member States, Croatia and the EEA countries (Iceland, 

Norway  and  Liechtenstein)  with  the  view  to  highlight  the  potential  impact  of  changes  in  lifestyle 

habits.  The  duration  of  the  contract  was  12  months  from  15  April  2013  with  a  price  of  EUR  245 

334,00 and an additional EUR 4 500 of reimbursement of expenses.  

Description and results 

The  study  aimed  to  disentangle  some  of  the  complexities  inherent  to  health-system  performance 

measurements  at  population  level  by  standardising  both  input  (expenditure)  and  outcome  (life 

expectancy)  indicators  for  the  prevalence  of  population  lifestyle  factors,  i.e.  apply  epidemiologic 

weighting techniques to improve the comparability of observations made at the Member State level. 

This way, a corrected (and more importantly, simplified) average cost-effectiveness measure could be 

calculated (money spent per life year), on which to base cross-country comparisons Further, based on 

assumed scenarios for changes in population lifestyle incremental cost-effectiveness estimations were 

also made (extra money spent/saved per added life year). 

The study covered the 27 EU Member States plus Croatia, Iceland, Liechtenstein and Norway, as well 

as the EU area as a whole. The output of the study was a picture of the potential impact that changes in 

lifestyle habits could have on health expenditure and health outcomes. 

The  result  was  an  improvement  on  the  state  of  the  art  knowledge  in  this  field:  in  other  words,  the 

application  of  the  revised  methodology  on  the  selected  data  sets  enables  better  cross-country 

comparisons and can help Member States learn from each other. 

The results are available in the final report available on the DG SANTE website21.  

21 https://ec.europa.eu/health/sites/health/files/systems_performance_assessment/docs/2015_maceli_report_en.pdf  

30 

 
 
 
                                                      
2.  SERVICE  CONTRACT:  The  review  and  mapping  of  continuous 

professional development and lifelong learning for health professionals 

in the EU 

Objective  

Falling under the field of health information, the present study, concerning the review and mapping of 

continuous  professional  development  and  lifelong  learning  for  health  professionals  in  the  EU  (also 

called the CPD study) was commissioned to a consortium led by the CPME, the standing committee of 

Europeans doctors. 

Description and results 

There is widespread recognition of the importance of continuous professional development and life-

long learning of health professionals.   These help to ensure that professional practice is up-to-date and 

to  contribute  to  improving  patient  outcomes  and  increase  public  confidence  in  the  professions. 

National  interpretations  offer  a  rich  scope  of  differing  approaches  and  present  opportunities  for  the 

identification of recommendations and best practices in the EU. 

This  study  comprises  a  unique  mapping  and  review  of  continuous  professional  development  and 

lifelong learning for doctors, nurses, dentists, midwives and pharmacists in the 28 member countries 

of  the  EU  and  EFTA  countries.  It  describes  the  policy  background  to  the  topic,  reviews  available 

literature  and  illustrates  the  outcomes  of  a  Europe-wide  survey  and  expert  workshop,  as  well  as 

presenting an overview of EU and European-level initiatives on continuous professional development. 

The  study  identifies  policy  recommendations  to  strengthen  the  exchange  of  cooperation  and  best 

practices at European level and highlighting the need to make efforts allowing all health professionals 

to undertake continuous professional development, including addressing the main barriers identified, 

these  being  a  lack  of  time  and  resources.  The  recommendations  also  call  for  more  research  into 

continuous professional development and its relation to patient safety and quality of care. For the full 

document with its result, please follow this link. 

31 

 
 
 
 
3.  SERVICE  CONTRACT:  Recruitment  and  Retention  of  the  Health 

Workforce in Europe  

Objective  

The study concerning in the field of health information the Recruitment and Retention of the Health 

Workforce  in  Europe  (RR-HWF)  has  been  commissioned  to  a  consortium  led  by  the  EHMA,  the 

European Health management association. 

Description and results 

Many  EU  countries  report  both  difficulties  in  retaining  and  recruiting  health  staff  frequently  allied 

with the challenge of balancing the right number of healthcare staff with the right skills in the right 

geographical areas to meet the changing needs of populations and health systems. These problems are 

becoming increasingly urgent as the healthcare demands increase, the health workforce shrinks, with 

many workers reaching retirement age, risking the future sustainability of Europe’s health systems and 

access to care. 

This  study  funded  under  the  EU  Health  Programme  included:  a  literature  review,  a  mapping  and 

review  of  recruitment  and  retention  practices  for  health  professionals;  eight  case  studies  addressing 

recruitment  and  retention  of  health  professionals  and  policy  and  management  recommendations  for 

policy makers, managers, health professionals, researchers and educators. The findings from the study 

identified many innovative solutions to the challenges of recruiting and retaining health staff.  

For the full document with its result, please follow this link22.  

4.  SERVICE CONTRACT: EUREST - Study on the development of an EU 

common  reporting  format  for  submission  of  data  on  ingredients 

contained  in  tobacco  and  related  products,  and  disclosure  of  the 

collected data to the public 

22 https://ec.europa.eu/health/workforce/key_documents/recruitment_retention_en 

32 

 
 
 
 
                                                      
Objective 

The EUREST study ran from 11 May 2014 for 11 months, and incurred a total cost of EUR 180 680. 

One key aspect of the current Tobacco Products Directive (2014/40/EU) (TPD) is the development of 

an  EU  common  reporting  format  for  submission  of  data  on  ingredients  contained  in  tobacco  and 

related  products  and  disclosure of the  collected data  to  the  public.  The Tobacco  Products  Directive 

seeks to further harmonise the approach on ingredients regulation in the context of the internal market 

and to rationalise the reporting system for manufacturers and importers. In this sense, it provides for a 

common and standardised electronic reporting format for all Member States for the reporting of a list 

of all ingredients (Article 5), including tobacco, additives, and any other substance or element present 

(Article  2(18))  in  a  finished  tobacco  product.  The  Tobacco  Products  Directive  also  provides  for  a 

common electronic notification format for electronic cigarettes and refill containers (Article 20).  

In order to make the  Tobacco Products Directive fully operational and to keep up with future trends in 

the  tobacco  sector,  delegated  and  implementing  powers  were  foreseen  to  amend  or  supplement  the  

Tobacco  Products  Directive and  to  give  effect  or  'shape  the  rules'  laid  down  in  the  basic  act. 

Accordingly, the Commission shall, by means of implementing acts, lay down the common format for 

the  submission  and  the  making  available  of  the  required  information  on  tobacco  products  (Article 

5(5)), as well as the common format for the notification of the required information on e-cigarettes and 

refill containers (Article 20(13)). 

Description and results 

This  study  rose  to  the  challenge  by  examining  the  reporting  formats  previously  used  in  the  EU  and 

other  jurisdictions  while  investigating  current  needs.  This  involved  outlining  the  strengths  and 

weaknesses  of  available  formats,  along  with  best  practices  and  cost/benefit  projections  for  each 

format.  The  study’s  results  paved  the  way  for  the  creation  of  a  common  EU  format  for  reporting 

tobacco product ingredients and the notification of e-cigarettes. The final and main deliverables of the 

EUREST project include a) two data dictionaries that incorporate the domains to be reported within 

the  common  reporting  format  for  tobacco  products  and  common  notification  format  for  e-cigarettes 

respectively and b) the pilot submission platform that is built on the aforementioned data dictionaries 

and  facilitates  the  electronic  submission  of  the  data.  These  helped  to  deepen  EU  authorities' 

knowledge of these products and their effects, strengthening their monitoring capacity and ability to 

take  action.    The  full  document  with  its  result  can  be  found  on  the  website  of  the  European 

33 

 
 
 
Commission's  DG Health and Food Safety.23 EUREST acted as the base on which EUREST-PLUS 

(European  Regulatory  Science  on  Tobacco:  Policy  implementation  to  reduce  lung  diseases)  was 

developed, a project funded by DG RTD under the 2015 GACD call on lung diseases. 

5.  SERVICE CONTRACT: Tobacco tracking & tracing  

Objective  

Considerable volumes of illicit tobacco products find their way in the EU every day. The availability 

of such products in the market doesn't only undermine the protection provided for by tobacco control 

legislation; it also has a direct and indirect adverse impact on public health: direct, as illicit products 

constitute  a  public  health  hazard;  indirect,  as  they  undermine  related  tax  receipts,  a  key  financial 

resource for health systems. 

Under  the  full  title  "Analysis  and  Feasibility  Assessment  Regarding  EU  systems  for  Tracking  and 

Tracing  of  Tobacco  Products  and  for  Security  Features", the  purpose  of  this  study  was  to  assist  the 

European Commission in the preparation for a European Union tracking and tracing system of tobacco 

products and for security features, as foreseen in the Tobacco products Directive. 

The  study  ran  from  28  November  2013,  until  January  2015,  with  a  total  cost  of  EUR  297  811. 

Eurogroup  Consulting  Portugal  –  Consultoria  em  gestão,  LDA  prepared  a  feasibility  assessment 

regarding EU systems for tracking and tracing of tobacco products and for security features (hereafter 

"the Feasibility Study").  

Description and results 

The  Feasibility  Study  reached  the  conclusion  that  full  traceability  of  EU  tobacco  products  is 

achievable  and  that  there  are  many  solutions  for  security  features  that  meet  the  Tobacco  Products 

Directive requirements. It thus presented four potential solutions for traceability and four for security 

features, each one reflecting the basic requirements made under the Tobacco Products Directive, i.e. a 

unique  identifier  must  be  affixed  to  a  unit  packet  at  the  manufacturing  site,  while  information  on  a 

unique  identifier  along  with  additional  information  required  by  Article  15(2),  which  are  generated 

23 https://ec.europa.eu/health/sites/health/files/tobacco/docs/reportingformat_dataingredients_en.pdf 

34 

 
 
 
 
                                                      
during production and distribution of tobacco products, must be saved at an independent data storage 

facility. The proposed traceability solutions are as follows:  

Option  1:  an  industry-operated  solution,  with  direct  product  marking  carried  out  by  tobacco 

manufacturers; manufactures are free to select an independent data storage provider. 

Option  2:  a  solution  operated  by  a  third  party  responsible  for  the  product  marking  process  on  the 

production line; the system operates with one central independent data storage provider. 

Option  3:  each  Member  State  selects  between  Option  1  and  2  regarding  the  entity  responsible  for 

product  marking  (manufacture  or  independent  solution  provider);  the  system  operates  with  multiple 

independent data storage providers.  

Option 4: a unique identifier is integrated with a security feature and affixed in the same process as a 

security feature; the system operates with (a) independent data storage provider(s). 

With  regards  to  the  solutions  for  security  features,  each  option  includes  several  levels  of  protecting 

features:  overt,  semi-covert,  covert  and  forensic.  On  the  basis  of  various  available  technologies  the 

Feasibility Study proposes the following four options: 

Option 1: a security feature using similar authentication technologies to a tax stamp. 

Option 2: reduced semi-covert elements as compared to Option 1, where the co-presence of a unique 

identifier is regarded as equivalent to the semi-covert level of protection. 

Option 3: the fingerprinting technology is used for the semi-covert and covert levels of protection. 

Option 4: a security feature is integrated with a unique identifier. 

The  Feasibility  Study  concluded  that  no  matter  which  traceability  and  security  feature  option  is 

selected,  the  benefits  clearly  outweigh  the  costs  from  both  economic  and  social  perspectives. 

However, it also recognises that the above options may vary in terms of the likelihood of achieving the 

full benefits expected from the introduction of traceability and security features.   

The  feasibility  study  was  the  first  step  in  a  series  of  actions  (including  other  studies,  as  the 

"Implementation  Study"  )  launched  to  assist  the  Commission  in  drafting  secondary  legislation  on 

traceability for tobacco products, on related data storage contracts and on security features applied to 

tobacco products. 

35 

 
 
 
The feasibility study was published on 7 May 2015 and can be found on the website of the European 

Commission's DG SANTE website.   

6.  SERVICE  CONTRACT:  Economic  landscapes  of  human  tissues  and 

cells for clinical application in the EU 

Objective  

The study on the Economic landscapes of human tissues and cells for clinical application in the 

EU  ran  from  December  2013  to  May  2015,  and  was  carried  out  by  a  consortium  led  by  Rathenau 

Institute. The total price was EUR 300 000.  

Description and results 

The safe and stable supply of tissues and cells for patients requiring transplantation is a key priority 

for national health authorities and the European Commission alike. Voluntary and unpaid donation are 

governing principles in this field, as laid down in EU legislation (Directive 2004/23/EC) and promoted 

by international organisations such as the WHO and Council of Europe. 

At  present,  the  main  concerns  are  to  maintain  an  adequate  supply  of  tissues  and  cells  for  patients 

requiring  transplantation  and  to  warranty  their  safety  and  quality.  The  field  of  tissues  and  cells 

contains three sectors: 

  Replacement tissues, such as bone, cornea, skin and cardiovascular tissues  

  Hematopoietic progenitor cells from bone marrow, peripheral blood and cord blood  

  Gametes and tissues for assisted reproductive technology 

This study mapped the economic landscapes and key players in the field of transplantation medicine 

across the three respective domains across all EU-28 Member States. The study focused on identifying 

current  and  emerging  economic  practices,  key  players  in  public  and  private  sectors,  legislative  and 

reimbursement  schemes  across  Member  States,  and  finally  on  providing  a  forecast  of  technological 

trends and of associated ethical, legal, and social issues. 

The final report provides insight into the following aspects: 

  The characteristics of the EU tissues and cells economic landscape, such as steps from donor 

recruitment through donation, procurement/collection, testing, processing, storage, distribution 

to clinical application. This section covers quantities, prices, the extent and ratio of Voluntary 

36 

 
 
 
and  unpaid  donation  versus  paid  donations,  concerns  and  conflicts,  supply  and  demand 

volumes  and  other  elements  in  order  to  better  understand  the  economic  parameters  and 

dynamics 

  The main actors involved in the different steps from donor recruitment to transplantation, for 

the EU-28 Member States, but also at the EU level, covering public and private actors in this 

sector  

  Regulations  on  reimbursement  and  financing  in  the  EU  Member  States  to  better  understand 

the  various  models  of  organization  of  reimbursement,  the  overall  costs  for  tissue 

transplantation,  including  transplant  tourism.  This  includes  also  compensation  schemes  for 

donors 

  A forecast for the EU economic landscape and trends for tissue and cells for transplantation 

and  assisted  reproduction  for  the  next  10  years,  with  respect  to  economic,  medical,  social, 

political  and  ethical  evolutions  in  the  different  sectors  within  the  field  of  tissues  and  cells 

markets.  This  includes  the  impact  of  future  technological  developments  and  their  respective 

needs for legal provisions to warranty safety and quality of tissue transplantation. 

The final report was published on this link24.  

24 http://publications.europa.eu/resource/cellar/5a0fd429-4a4e-11e6-9c64-01aa75ed71a1.0001.02/DOC_1 

37 

 
 
 
 
 
 
                                                      
HIGHLIGHTS  OF  CO-FUNDED  ‘CROSS-CUTTING’  AND 

‘OTHER’ ACTIONS 

1.  Dissemination activities carried out in 2015 

The  need  to  improve  the  outreach  of  the  Health  Programme  with  more  and  better  targeted in  scope 

dissemination  actions  was  highlighted  in  the  final  evaluation  of  the  second  Health  Programme.  In 

response,  CHAFEA  organised  several  workshops,  collaborated  in  major  national  and  international 

conferences,  or  organized  stand-alone  events  in  collaboration  with  EU  Member  States  national 

authorities.  

It further participated with the Health Programme's pop-up stands and dissemination material in more 

than 20 events, of national or EU dimension. The following events can be highlighted:  

A  two-day  workshop  on  Chronic  Diseases  and  Healthy  Ageing  (CD-HA)  took  place  on  February 

2015,  in  The  Hague,  the  Netherlands.  Organised  in  collaboration  with  the  Netherlands  Enterprise 

Agency and Ministry of Health, Welfare and Sport, it brought together 115 participants, mainly policy 

makers and experts from 6 EU countries (Belgium, France, Germany, Ireland, UK and Spain).  

A  Conference  on  Mental  Health  in  All  Policies,  titled  "Supporting  sustainability  and  growth  in 

Europe"  was  held in  Helsinki  in  May  2015,  with the  support  of  the  Finnish Ministry  of  Health and 

Finland's national association for mental health. The meeting brought together more than 150 experts, 

policy makers and stakeholders from 7 Member States (Finland, Norway, Sweden, Denmark, Estonia, 

Latvia and Lithuania). 

Two  workshops  and  a  symposium  were  organised  in  the  framework  of  the  Addictions  2015 

conference, in  September 2015,  Lisbon,  Portugal,  organised  by  SICAD  (Serviço  de  Intervenção  nos 

Comportamentos Aditivos e nas Dependências), in collaboration with EMCDDA, DG SANTE and DG 

HOME.  The  aim  of  the  workshops  was  to  discuss  progress  and  challenges  in  providing  health 

interventions  such  as  prevention,  harm  reduction  and  treatment  for  addictive  substance-related 
problems, with a total of 101 participants25.  

25 http://ec.europa.eu/CHAFEA/news/news381.html 

38 

 
 
 
                                                      
In addition, CHAFEA contributed to the final dissemination conference of the Joint Action Achieving 

Comprehensive Coordination in Organ Donation throughout the European Union (JA ACCORD) on 

organ  donation  implemented  by  Member  States,  held  in  Madrid  on  2  June  2015,  where  the 

achievements of EU-wide collaboration in this area were presented also to the press.  

CHAFEA  organised  a  full  day  workshop  in  the  framework  of  the  8th  European  Public  Health 

Conference,  showcasing  the  contribution  of  the  Health  Programme  co-funded  actions  in  the  area  of 

health  systems  as  identified  in  the  communication  on  effective,  accessible  and  resilient  health 

systems.  Bringing  together  more  than  80  experts,  health  professionals,  policy  makers  and  project 

leaders the event also highlighted the role played by public health professionals in sharing experiences 

and transferring knowledge across the EU.  

Following  the  publication  of  the  2015  work  programme,  CHAFEA  contributed  to  15  national  or 

regional  information day  events  in  the  countries  participating  in  the  Health  Programme.  It  also  held 

three National Focal Point meetings.  

The  final  versions  of  the  thematic,  so-called  "info  sheets",  covering  important  areas  of  the  Health 

Programme  (English  versions)  have  been  delivered  and  are  available  in  several  EU  languages  on 
CHAFEA's website26 .  

Two brochures were also finalised: one on the joint actions and the other covering all the actions co-

funded in 2013.  

Finally,  so  as  to  better  plan  its  dissemination  activities,  those  funded  by  the  Health  Programme 

operational  budget,  or  from  CHAFEA's  administrative  budget,  the  Agency  launched  a  tender  to 

develop a comprehensive communication and disseminations strategy for the years to follow (covering 

the remaining duration of the third Health Programme in 2020). 

2.  Other Actions  

Scientific Committees  
In 2015, a total of EUR 240 991 EUR was provided under the Third Health Programme to part-fund 

the  activities  of  the  non-food  Scientific  Committees  SCHER  (Scientific  Committee  on  Health  and 

Environmental Risks) and SCHENIR (Scientific Committee on Emerging and Newly Identified Health 

26 http://ec.europa.eu/CHAFEA/health/hp-infosheets_en.html 

39 

 
 
 
                                                      
Risks).  The  third  Committee,  the  SCCS (Scientific  Committee  on  Consumer  Safety),  was  funded 

under  the  Consumers  Programme.  These  Committees  are  managed  by  the  Directorate-General  for 

Health and Food Safety. 

The  purpose  of  the  Committees  is  to  assist  the  Commission  by  providing  it  with  sound  scientific 

advice  when  preparing  its  policies  and  proposals  related  to  consumer  safety,  health  and  the 

environment, and draw its attention to new and emerging problems. 

The two Committees SCHER and SCHENIR produced the following Opinions in 2015: 

-  SCHER Opinions 

-  New conclusions regarding future trends of cadmium accumulation in EU arable soils 

-  Opinion on Chromium VI in toys 

SCHENIR Opinions: 

-  Opinion on the safety of surgical meshes used in uro-gynaecological surgery  

-  Opinion  on  the  safety  of  medical  devices  containing  DEHP-plasticized  PVC  or  other 

plasticizers on neonates and other groups possibly at risk  

-  Opinion  on  the  safety  of  dental  amalgam  and  alternative  dental  restoration  materials  for 

patients and users 

-  Opinion on the safety of the use of bisphenol A in medical devices 

-  Opinion on Guidance on the Determination of Potential Health Effects of Nanomaterials Used 

in Medical Devices  

-  Opinion on potential health effects of exposure to electromagnetic fields  

Joint SCCS/SCHER/SCHENIR Opinions: 

-  Final opinion on Synthetic Biology III - Risks to the environment and biodiversity related to 

synthetic biology and research priorities in the field of synthetic biology 

-  Final opinion on Synthetic Biology II - Risk assessment methodologies and safety aspects 

The Programme also provided EUR 201 600 EUR to help fund the scientific and technical assistance 

provided by external contractors. This assistance included organising scientific hearings and thematic 

workshops,  performing  literature  searches,  proofreading,  editing  and  translating  scientific  texts  into 

publications for the general public and updating the scientific committees’ website. 

40 

 
 
 
In  December  2015,  the  Secretariat  organised  a  Conference  on  Synthetic  Biology,  following  the 

publications of the 3 joint Opinions. 

Expert Panel of Health  

An Expert Group on Health Systems Performance Assessment was established in November 2014. In 

2015 the Group focused on the assessment of quality care.  

Expert Panel on effective ways of investing in health 

The  Expert  Panel  on  effective  ways  of  investing  in  health  is  an  interdisciplinary  and  independent 

group established by the European Commission to provide non-binding advice on matters related to 

effective, accessible and resilient health systems.  

The creation of the Panel goes back to the conclusions on health systems adopted in June 2011 by the 

Council  of  Ministers  of  the  EU,  which  invited  the  European  Commission  to  initiate  a  process  to 

provide with independent and evidence-based advice on health systems related questions is crucial in 

order to support policy making on health. 

Since starting its activities on 11 July 2013, the Expert Panel has been working consistently on topical 

questions  issued  by  the  Commission.  The  opinions  of  the  Expert  Panel  present  the  views  of  the 

independent scientists who are members of the Expert Panel. They do not necessarily reflect the views 

of the European Commission. 

The  areas  of  competence  of  the  Expert  Panel  include,  but  are  not  limited  to,  primary  care,  hospital 

care,  pharmaceuticals,  research  and  development,  disease  prevention  and  health  promotion,  social 

protection, cross-border cooperation, health economics, eHealth and health education and literacy. 

The  Expert  Panel  delivers  opinions,  which  can  support  health  policy  making  in  the  EU.  These 

opinions  are  for  the  consideration  of  the  Member  States'  governments  and  authorities  in  charge  of 

delivering  healthcare.  They  are  also  for  the  consideration  of  various  stakeholders.  They  aim  at 

generating discussions at EU and national level with a view to inform policy making. They have all a 

particular focus on the added value that the EU level can bring through mutual learning, best practice 

identification and knowledge brokering.  

41 

 
 
 
 
 
 
The  first  three-year  term  of  the  panel  ended  in  May  2016.  The  renewed  panel  of  14  members  was 

appointed in November 2016, and it serves a three-year term, ending in May 2019.  

List of Expert Panel opinions in 2015: 

  Cross-border Cooperation  
  Competition among health care providers in the European Union - Investigating policy options 

42 

 
 
 
 
 
IMPLEMENTATION OF ANNUAL WORK PROGRAMME 2015  

CALLS FOR PROPOSALS 

Calls  for  proposals  —  for projects and operating  grants actions  —were  launched  on 5 June 2015  on 
the Participant Portal of the Horizon 2020 Programme,27 the public health website on EUROPA28 and 
on  Chafea’s  website.29  Most  applications  were  received  from  main  partners  (namely,  leading 

coordinators)  in  EU-15  Member  States,  who  accounted  for  68 %  of  project  applications,  100 %  of 

operating grant applications, and 100 % of joint action applications. The percentage of new EU MS 

involved in the joint actions is 46.4% of all partners, whereas for projects it is 39.1%.   

Chafea  organised  a  joint  action  workshop  in  November  2015  and  a  joint  action  quality  assurance 

workshop  in  February  2016.  The  National  Focal  Points  for  the  Health  Programme  also  organised 

national  information  days  throughout  June  and  July  2015.  Guidelines  for  applicants  were  made 

available on the Participant Portal. The Chafea helpdesk also provided assistance and practical help. 

Altogether, 79 proposals for projects and 15 operating grant proposals were received with a proposal 

budget amounting for a total EUR  200 088 946.14; however the annual available budget was EUR  13 

650  000.00.  Of  these,  1  was  ineligible,  2  inadmissible,  1  withdrew.  As  an  outcome,  29  of  the  79 

remaining  applications  (46  were  rejected)  were  funded  (37 %).  Applications  were  evaluated  in 

accordance with the rules and criteria set out in Commission Implementing Decision C (2014) 3383 

and the calls for proposals. 19 external experts from 14 countries took part in the evaluation process. 

The experts were drawn from a list established following a call for expressions of interest entitled ‘call 
for expressions of interest in the area of public health’.30 

The evaluation process took place in two stages. 

In the first stage, three external evaluators reviewed each proposal. A consolidated evaluation report 

for each proposal was drawn up at a consensus meeting organised by Chafea. 

27http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/3hp/index.html#c,calls=hasForthcomi
ngTopics/t/true/0/1/0&hasOpenTopics/t/true/0/1/0&allClosedTopics/t/true/1/1/0&+PublicationDate/desc  
28 https://ec.europa.eu/health/funding/programme_en  
29 http://ec.europa.eu/CHAFEA/health/index.html  
30 OJ S 040-065407, 26.2. 2014 and http://ec.europa.eu/CHAFEA/ami/  

43 

 
 
 
 
                                                      
In  the  second  stage,  the  evaluation  committee  checked  that  the  evaluators  had  complied  with  the 

relevant rules and criteria. It then drew up final lists of proposals recommended for funding, together 

with reserve lists. The evaluation committee comprised representatives from the Directorate-General 

for Health and Food Safety (DG SANTE), the Directorate-General for Research and Innovation and 
from Chafea. The award decision for projects31 and operating grants32 were taken by Chafea. 

Project grants 

Project  grants  were  awarded  to  actions  involving  several  partners,  usually  public  health  bodies  and 

non-governmental  organisations. The  maximum  EU  contribution  is  60%  of  eligible  costs.  However, 

the EU contribution may go up to 80% if a proposal meets the criteria for exceptional utility. In 2015, 
2 projects qualified for exceptional utility as presented in the 2015 work programme33. 

In all, 79 proposals were submitted in response to the call for proposals for projects. 29 proposals were 

recommended for funding and 9 were placed on a reserve list. In the end, 12 projects were funded for a 

total of EUR 14 944 000,04. Their distribution among the programme objectives was as follows: 

1.  Health promotion: EUR  2 922 735,89 (4projects) 

2.  Health threats: no project call 

3.  Health systems: EUR  3 395 207,18 (2projects) 

4.  Better and safer healthcare: EUR 1 456 597.00 (2 projects) 

In  addition  and  in line  with  the  amended  2015  work  programme,  4  projects  were  funded  to  support 

Member  States  to  migratory  pressure  in  their  response  to  health  related  challenges.  The  co-funding 

amount was EUR 6 234 199.58  

31 http://ec.europa.eu/CHAFEA/documents/health/list-projects-2014_en.pdf  
32 http://ec.europa.eu/CHAFEA/documents/health/award-fpa-agreements-2014_en.pdf   and    
http://ec.europa.eu/CHAFEA/documents/health/specific-grant-agreements-2014_en.pdf 
33 https://ec.europa.eu/health//sites/health/files/programme/docs/wp2015_annex_en.pdf  

44 

 
 
 
 
 
                                                      
The table lists all projects funded per objective and thematic priority. 

Financial 
Instrument 

Objective's 
description: 

Thematic priority: 

CHAFEA Project Grants by objective and priority 

1. Promote health, prevent diseases and foster supportive 
environments  for  healthy  lifestyles  taking  into  account 
the 'health in all policies' principle 

1.1 Cost-effective promotion and prevention measures in 
line,  in  particular,  with  the  Union  strategies  on  alcohol 
and  nutrition,  and  including  actions  to  support  the 
exchange  of  evidence-based  and  good  practices  for 
addressing risk factors 

User reference 

Title 

709661 - SIE -  HP-
PJ-2015 

STAD in Europe 

Amount EUR 

698 416.59 

710063 
- 
ALLCOOL  -  HP-
PJ-2015 

Raising  awareness  and  action-research  on  Heavy 
Episodic Drinking among low income youth and young 
adults in Southern Europe 

236 843.80 

Total 

Thematic priority: 

935 260.39 

to  communicable 
1.3  Support  effective  responses 
diseases  such  as  HIV/AIDS,  tuberculosis  and  hepatitis 
by  identifying,  disseminating  and  promoting  the  uptake 
of  evidence-based  and  good  practices  for  cost-effective 
prevention, diagnosis, treatment and care 

User reference 

Title 

Amount EUR 

- 

709624 
E-
DETECT TB - HP-
PJ-2015 

- 

709844 
HEPCARE 
EUROPE  -  HP-PJ-
2015 

Total 

European Cornea and Cell Transplantation Registry 

1 852 745.00 

HepCare Europe: 

1 069 990.89 

2 922 735,89 

45 

 
 
 
 
 
 
 
 
 
 
Thematic priority: 

3.5. Address health issues in an ageing society  

User reference 

Title 

Amount EUR 

Advancing  Care  Coordination 
deployment at Scale 

and  Telehealth 

2 072 432.18 

Scaling Integrated Care In Context 

1 322 775.00 

709770  -  ACT-AT-
SCALE  -  HP-PJ-
2015 

- 
710033 
SCIROCCO  -  HP-
PJ-2015 

Total 

Objective's 
description: 

4.  Facilitate  access  to  better  and  safer  healthcare  for 
Union citizens 

Thematic priority: 

4.5 Implementation of Union legislation in the fields of 
human  tissues  and  cells,  blood,  human  organs,  medical 
devices,  medicinal  products,  and  patients’  rights  in 
cross-border health care 

User reference 

Title 

Good  Practices  for  demonstrating  safety  and  quality 
through recipient follow-up 

European Cornea and Cell Transplantation Registry 

424 567.00 

709567 
-  EURO-
GTP  II  -  HP-PJ-
2015 

709723  -  ECCTR  - 
HP-PJ-2015 

Total 

Objective's 
description: 

6.  Support  Member  States  under  particular  migratory 
pressure  in  their  response  to  health  related  challenges 
(Horizontal action related to objectives 1 and 2) 

Thematic priority: 

Horizontal migration 

User reference 

Title 

- 

SH-
717275 
CAPAC  -  HP-HA-
2015 

Supporting  health  coordination    assessments    planning  
access  to  health  care  and  capacity  building  in  Member 
States under particular migratory pressure (SH-CAPAC) 

717307  -  8  NGOS 
IN  11  STATES  - 

8  NGOs  for  migrants/refugees'  health  needs  in  11  2 756 269.00 

46 

3 395 207,18 

Amount EUR 

1 032 030.00 

1 456 597.00 

Amount EUR 

537 044.34 

 
 
 
 
 
 
 
 
 
 
 
HP-HA-2015 

countries 

717317  -  CARE    - 
HP-HA-2015 

Commmon  Approach  for  REfugees  and  other  migrants' 
health 

1 689 045.11 

717319 
-  EUR-
HUMAN - HP-HA-
2015 

Total 

CHAFEA  TOTAL 
PROJECTS  

EUropean  Refugees  -  HUman  Movement  and  Advisory 
Network 

1 251 841.13 

6 234 199.58 

14 944 000.04 

Operating grants 

Operating grants were awarded to non-profit organisations or networks that are: 

  Non-governmental 

  Non-profit-making and independent of industry, commercial and business or other conflicting 

interests 

  Working in the public health area 

  Play an effective role in civil dialogue processes at Union level 

  Pursue at least one of the specific objectives of the Programme 

  Active at Union level and in at least half of the Member States; and 

  Have a balanced geographical coverage of the Union 

The maximum EU contribution is 60 % of their annual operating costs. However, the EU contribution 

may increase to 80 % if a proposal meets the criteria for exceptional utility. In 2015, only 6 operating 

grants qualified for exceptional utility. 

With the start of the third Health Programme, Chafea introduced the call for multi-annual ‘framework 

partnership’  instrument.  The  holders  of  three-year  framework  partnership  agreements  can  apply  for 

annual co-funding. The 2015 annual work programme did not foresee an open call for operating 

grants,  as  organisations  having  signed  a  Framework  Partnership  Agreement covering  the  period 

2015-2017 were invited to submit their Specific Grant Agreement proposals. 14 applicants were 

granted  a  Framework  partnership  agreement.  However,  only  13  applicants  received  a  specific 

47 

 
 
 
 
 
 
 
grant agreement. At the end of 2015, the grant preparation process was completed representing a 

volume of EUR 5 005 520. One of the framework partnership agreement holders could not submit 

their specific grant agreement proposal for 2016 due to the bankruptcy of the legal entity hosting 

the specific network of experts. 

The table lists all operating grants funded by objective and priority. 

709736 
- 
SOEEF2016  -  HP-
ADHOC-2014-
2020-SGA-2015 

709876 
-  EPHA 
SGA  2016  -  HP-
ADHOC-2014-
2020-SGA-2015 

- 
709966 
VULNERABILITY 
NW - HP-ADHOC-
2014-2020-SGA-
2015 

Total 

Thematic priority: 

Improving  health  care  for  adults  and  children  with 
intellectual disabilities. 

162 073.00 

EPHA Operating Grant Proposal 2016 SGA 

661 956.00 

European network to reduce vulnerabilities in health 

339 751.00 

2 105 541.00 

1.3  Support  effective  responses 
to  communicable 
diseases  such  as  HIV/AIDS    tuberculosis  and  hepatitis 
by identifying  disseminating and promoting the uptake 
of  evidence-based  and  good  practices  for  cost-effective 
prevention  diagnosis  treatment and care 

User reference 

Title 

Amount EUR 

709438  -  TBEC  - 
HP-ADHOC-2014-
2020-SGA-2015 

709680 - AAE - HP-
ADHOC-2014-
2020-SGA-2015 

 Total 

Strengthening  the  role  of  civil  society  within  the  TB 
response in Europe 

86 858.00 

AIDS Action Europe - Continuity and Innovation 2016 

265 724.00 

352 582.00 

48 

 
 
 
 
 
 
Amount EUR 

434 192.00 

766 731.00 

Amount EUR 

792 021.00 

792 021.00 

Thematic priority: 

1.4 Support cooperation and networking in the Union in 
relation  to  preventing  and  improving  the  response  to 
chronic  diseases  including  cancer    age-related  diseases 
and neurodegenerative diseases 

User reference 

Title 

Alzheimer Europe 2016 

Cancer Leagues Collaborating in Cancer Prevention and 
Control at the National and European Level 

332 539.00 

707934  -  AE2016  - 
HP-ADHOC-2014-
2020-SGA-2015 

709864  -  ECL  SGA 
2016 
HP-
- 
ADHOC-2014-
2020-SGA-2015 

 Total 

Objective's 
description: 

4.  Facilitate  access  to  better  and  safer  healthcare  for 
Union citizens 

Thematic priority: 

4.2  Coordinated  action  at  Union  level  in  order  to 
effectively help patients affected by rare diseases 

User reference 

Title 

- 
709986 
EURORDIS  SGA 
2016 
HP-
- 
ADHOC-2014-
2020-SGA-2015 

 Total 

Thematic priority: 

EURORDIS SGA 2016 

4.3  Strengthen  collaboration  on  patient  safety  and 
quality of health care 

User reference 

Title 

Amount EUR 

709743 - EPF-SGA-
2016 
HP-
- 
ADHOC-2014-
2020-SGA-2015 

 Total 

European  Patients'  Forum  -  Specific  Grant  Agreement 
2016 

735 645.00 

735 645.00 

49 

 
 
 
 
 
 
 
 
 
 
Thematic priority: 

4.5 Implementation of Union legislation in the fields of 
human tissues and cells  blood  human organs  medical 
devices    medicinal  products    and  patients’  rights  in 
cross-border health care 

User reference 

Title 

HAI_FY2016 

- 
709635 
HAI_FY2016  -  HP-
ADHOC-2014-
2020-SGA-2015 

 Total 

CHAFEA  TOTAL 
OPERATING 
GRANTS 

Joint actions 

Amount EUR 

253 000.00 

253 000.00 

5 005 520.00 

Grants  for  joint  actions  were  awarded  to  competent  authorities  or  public  sector  bodies  and  non-

governmental  bodies  mandated  by  those  competent  authorities.  The  maximum  EU  contribution  is 

60 %. However, the EU contribution may go up to 80 % if a proposal meets the criteria for exceptional 

utility. In 2015, none of the joint actions qualified for exceptional utility. 

The procedure for joint actions under the new Health Programme has changed. In order to assure more 

transparency  and  inclusiveness,  the  Member  States  and  countries  participating  in  the  Third  Health 

Programme nominate the competent authorities or other bodies as a first step. In the second step, those 

nominated are invited to submit a proposal under the direct grant procedure. 

Four joint actions were co-funded for a total of EUR 17 791 725.60. They were distributed among the 

programme objectives as follows: 

  Health promotion (no joint actions) 

 

 Health threats (no calls) 

  Health systems (3 joint actions):  EUnetHTA Joint Action 3 -  European Network for Health 

Technology Assessment (EUR  11 999 798.74);    Joint Action JAMS - Market surveillance of 

medical devices (EUR 849 487.69); Joint action ADVANTAGE on Managing Frailty: A 

50 

 
 
 
 
 
 
 
comprehensive approach to promote a disability-free advanced age in Europe: the 

ADVANTAGE initiative (EUR 3 442 591.13) 

  Better and safer healthcare (1 joint action):  JARC - Joint Action on Rare Cancers -  (EUR 1 

499 848.04) 

These  joint  actions  each  involved  between  10  and  45  beneficiaries  from  across  the  EU  and  other 

countries participating in the programme.  

The table below lists all the joint actions funded per objective and priority.  

Financial 
Instrument 

Objective's 
description: 

Thematic priority: 

CHAFEA Joint Actions by objective and priority 

3.  Contribute  to  innovative    efficient  and  sustainable 
health systems 

3.1  Support  voluntary  cooperation  between  Member 
States  on  health  technology  assessment  under  the 
network  on  health  technology  assessment  set  up  by 
Directive 2011/24/EU 

User reference 

Title 

European  Network  for  Health  Technology  Assessment 
(EUnetHTA) - Joint Action 3 

- 
724130 
EUnetHTA  JA3  - 
JA-01-2015 

 Total 

Financial Instrument 

Joint Action 

Thematic priority: 

3.5. Address health issues in an ageing society  

User reference 

Title 

724099 
ADVANTAGE 
JA-02-2015 

- 
- 

to 
Managing  Frailty.  A  comprehensive  approach 
promote  a  disability-free  advanced  age  in  Europe:  the 
ADVANTAGE initiative 

 Total 

Amount EUR 

11 999 798.74 

11 999 798.74 

Amount EUR 

3 442 591.13 

3 442 591.13 

51 

 
 
 
 
 
 
 
 
 
 
 
 
Thematic priority: 

3.6  Implementation  of  Union  legislation  in  the  field  of 
medical  devices    medicinal  products  and  cross-border 
health care 

User reference 

Title 

Amount EUR 

Market surveillance of medical devices 

849 487.69 

849 487.69 

Amount EUR 

1 499 848.04 

1 499 848.04 

17 791 725.60 

723964  -  JAMS  - 
JA-03-2015 

Total 

Objective's 
description: 

4.  Facilitate  access  to  better  and  safer  healthcare  for 
Union citizens 

Thematic priority: 

4.2  Coordinated  action  at  Union  level  in  order  to 
effectively help patients affected by rare diseases 

User reference 

Title 

Joint Action on Rare Cancers 

724161  -  JARC  - 
JA-04-2015 

Total 

CHAFEA  TOTAL 
JOINT ACTIONS 

52 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Direct grant agreements and Presidency Conferences 

Direct grant agreements 

Direct grant agreements with international organisations were awarded to international organisations 

active  in  the  area  of  public  health.  The  direct  grants  also  include  service-level  agreements.  The 

maximum EU contribution is 60 %. 

All in all, 10 direct grant agreements were signed, for a total of EUR 3 835 747.29 as follows: 

Seven direct grant agreements were signed by Chafea for EUR 3 715 000, namely: 

1)  5 direct grants were signed with the OECD regarding economics of prevention, Health Report 

2016, health workforce, antimicrobial resistance, and data analysis of data patient safety 

2)  1 direct grant was signed with IOM to support Member States under particular migratory 

pressure in their response to health related challenges  

3)  1 direct grant was signed with COE EDQM for the European Pharmacopoeia 2016 Activity 

Programme (CoE – EDQM) 

3 were signed by DG SANTE for EUR 120 747.29, namely: 

1)  1 direct grant was signed with the Department of Health in Ireland on the inventory on 

Morbidity Statistics at national level 

2)  1 direct grant was signed with the "Statistisches Bundesamt" in Germany on the inventory on 

Morbidity Statistics at national level 

3)  1 direct grant was signed with the "Centraal Bureau voor Statistiek" in the Netherlands on 

Health Care Non Expenditure Statistics to support countries in their capacity to provide data 

on health care 

The  table  below  lists  all  direct  grant  agreements  that  were  funded  per  objective  and  priority. 

53 

 
 
 
 
 
 
Financial 
Instrument 

Objective's 
description: 

SANTE Direct Grants by objective and priority 

1. Promote health, prevent diseases and foster supportive 
environments  for  healthy  lifestyles  taking  into  account 
the 'health in all policies' principle 

Thematic priority: 

1.6 Health information and knowledge system 

User reference 

Title 

Amount EUR 

07154.2015.003-2015.808 
HEALTH IRELAND / F.5 

/  DEPARTMENT  OF 

39 353.00 

07154.2015.003-2015.807 / DESTATIS / F.5 

 34 684.24 

 Total 

Objective's 
description: 

3. Contribute to innovative, efficient and sustainable 
health systems 

Thematic priority: 

3.7. Foster a health information and knowledge system 
to contribute to evidence-based decision-making 

User reference 

Title 

07154.2015.002-2015.734 / STATISTICS 
NETHERLANDS / F.5 

 Total 

Sante TOTAL 
DIRECT GRANTS 

 74 037.24 

Amount EUR 

46 710.05 

46 710.05 

120 747.29 

54 

 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Presidency Conferences 

In  2015,  SANTE  together  with  the  Luxembourgish  Presidency,  organised  the  high-level  Presidency 
Conference: "Making Access to Personalised Medicine a Reality for Patients". Both public health and 
examples of EU- and US-funded research initiatives were discussed. Its main findings contributed to 
the Council Conclusions adopted by the Council of Health ministers on 8 December 2015. 

The  second  co-funded  conference,  under  the  Netherlands  Presidency  of  the  Council,  addressed  the 
challenges of tackling antimicrobial resistance as a major cross-border health threat. Bringing together 
health  and  agriculture  ministers,  it  emphasized  the  “one-health”  approach.  By  drawing  on  a  mix  of 
disciplines including human and animal health, the environment and agriculture, it was instrumental to 
the adoption of the Council conclusions of 17 June 2016 and the EU One Health Action Plan against 
AMR. 

Financial Instrument 

CHAFEA Presidency Conferences by objective and priority 

Objective's description: 

4. Facilitate access to better and safer healthcare for Union citizens 

Thematic priority: 

4.3 Strengthen collaboration on patient safety and quality of health care 

User reference 

Title 

Amount EUR 

01 

00 

2015 
PERSONALISED 
MEDICINE 
PRESIDENCY 
CONFERENCE 
LUXEMBOURG 

PERSONALISED  MEDICINE 
LUXEMBOURG34 

-  PRESIDENCY  CONFERENCE  OF 

20 434.90 

- 

- 

OF 

 Total 

Thematic priority: 

4.4 Improve the prudent use of antimicrobial agents and reduce the practices 
that increase antimicrobial resistance 

20 434.90 

User reference 

Title 

conference 
‘Antimicrobial resistance’ under the Dutch Presidency 

713955  -  EU.NL-AMR  - 
HP-ADHOC-2014-2020-
PC-2015 

 Total 

CHAFEA 
PRESIDENCY 
CONFERENCES 

TOTAL 

Amount EUR 

on 

100 000.00 

100 000.00 

120 434.90 

34 http://www.eu2015lu.eu/en/agenda/2015/07/08-conf-medecine-personnalisee/index.html 

55 

 
 
 
 
 
 
 
 
 
 
 
                                                      
Procurements (service contracts) 

Procurement  (service  contracts)  was  used  to  purchase  services.  Contrary  to  the  grants,  the  Health 

Programme covers the full cost of the procurement action. 

These service contracts cover needs as specified in the work plan for 2015: 

  Evaluation and monitoring of actions and policies 

  Studies 

  Advice 

  Data and information on health 

  Scientific and technical assistance 

  Communication 

  Dissemination 

  Awareness-raising activities; and 

 

It applications to support policies 

In 2015, DG SANTE signed several service contracts and specific requests using existing framework 

contracts. Most of these contracts and requests were for horizontal actions such as communication and 

IT services for maintenance and functioning of existing IT tools (i.e. the EMP database, EUDAMED, 

Health Policy Platform, etc.).  

Procurement contracts also included contracts with experts working for the scientific committees and 

evaluation  and  monitoring  studies.  The  overall  public  procurement  budget  implemented  by  DG 

SANTE under AWP 2015 was EUR 5 744 988.82.  

The  overall  public  procurement  budget  implemented  by  Chafea  under  AWP  2015  was  EUR  5  890 
424.70.  In  2015,  Chafea  managed  11  new  market  procedures  for  the  acquisition  of  services  (2 
contracts under health promotion, 3 contracts under health threats, 2 contracts under health systems, 2 
under better and safer health care) and 2 on horizontal communication.  

The amounts per objective and authorising organisation were as follows: 

56 

 
 
 
 
 
Health Programme objective 

Procurement managed 

Procurement managed by 

Health promotion 

Health threats 

Health systems 

by DG SANTE (EUR) 

670 191.61 

Chafea (EUR) 

2 799 992.00  

0 

1 398 928.80 

2 113 713.26 

1 014 238.90  

Better and safer healthcare 

381 372.23 

399 005.00  

Horizontal 

TOTAL 

2 579 711.72 

278 260.00  

5 744 988.82 

5 890 424.70 

The table below lists all service contracts signed per objective and per priority by Chafe and by DG 

SANTE. 

Financial Instrument  CHAFEA Calls for tenders by objective 

Objective's 
description: 

1.  Promote  health    prevent  diseases  and  foster  supportive 
environments  for  healthy  lifestyles  taking  into  account  the 
'health in all policies' principle 

Thematic priority: 

1.3  Support  effective  responses  to  communicable  diseases 
such  as  HIV/AIDS    tuberculosis  and  hepatitis  by  identifying  
disseminating  and  promoting  the  uptake  of  evidence-based 
and  good  practices  for  cost-effective  prevention    diagnosis  
treatment and care 

User reference 

Title 

Amount EUR 

01 

2015 
71 
CHAFEA/2015/Healt
h/38 - HIV Training 

- 

behavioural survey for HIV/AIDS 

1 999 992.00 

Total 

1 999 992.00 

57 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thematic priority: 

required  by 

the 
1.5  Actions 
implementation  of  Union  legislation  in  the  field  of  tobacco 
products  advertising and marketing 

  or  contributing 

to 

User reference 

Title 

Specific 
under 
DI/07171 
LOT2 

the 

Contract 
FWC 
ABCIII 

Implementation 
analysis 
regarding  the  technical  specification  and  other  key  elements 
EU 
for 
system  for  traceability  and  security  features  in  the  field  of 
tobacco products. 

future 

a 

Total 

Objective's 
description: 

2.  Protect  Union  citizens  from  serious  cross-border  health 
threats 

Amount EUR 

800 000.00 

800 000.00 

Thematic priority: 

2.2  Support  capacity-building  against  health 
Member States 

threats 

in 

User reference 

Title 

Amount EUR 

2015  72  02  RFS  16  - 
CHAFEA/2015/HEA
LTH/17 
N°EAHC/2012/HEA
LTH/01)  

(FWC 

-  SC 

2015  72  04 
implementing 
Framework  Contract 
№ 
EAHC/2012/Health/0
1 
for 
-  Request 
Specific Service № 18 
CHAFEA/2015/Healt
h/19 

2015  72  05  RFS  19  - 
CHAFEA/2015/HEA
LTH/20 
N°EAHC/2012/HEA
LTH/01) 

(FWC 

Total 

HS ASSESSMENT AND BEST PRACTICES (TOOLKITS) 

509 826.00 

HS GENERIC PREPAREDNESS 

585 612.80 

 HS LAW NETWORK 

303 490.00 

1 398 928.80 

58 

 
 
 
 
 
 
 
 
 
Objective's 
description: 

3.  Contribute  to  innovative    efficient  and  sustainable  health 
systems 

Thematic priority: 

3.4.  Provide  expertise  and  share  good  practices  to  assist 
Member  States  undertaking  health  system  reforms  by  setting 
up  a  mechanism  for  pooling  expertise  at  Union  level  to 
provide  sound  and  evidence-based  advice  on  effective  and 
efficient investment and innovation in public health and health 
systems.  Facilitate  the  uptake  of  the  results  streaming  from 
research  projects  supported  under  the  Seventh  Framework 
the  European  Community  for  research 
Programme  of 
technological  development  and  demonstration  activities 
(2007-2013) and in the long term the activities which will be 
undertaken  in  the  Framework  Programme  for  Research  and 
Innovation (Horizon 2020). 

User reference 

Title 

Amount EUR 

CHAFEA/2015/Healt
h/06 - ESIF 

 Total 

Thematic priority: 

European Structural Investment funds 

724 960.00 

3.7.  Foster  a  health  information  and  knowledge  system  to 
contribute to evidence-based decision-making 

724 960.00 

User reference 

Title 

Amount EUR 

CHAFEA/2015/Healt
h/08 

Total 

Objective's 
description: 

Health System Performance Assessment 

289 278.90 

4.  Facilitate  access  to  better  and  safer  healthcare  for  Union 
citizens 

289 278.90 

Thematic priority: 

4.3  Strengthen  collaboration  on  patient  safety  and  quality  of 
health care 

User reference 

Title 

Amount EUR 

59 

 
 
 
 
 
 
 
 
 
 
HEALTH ECONOMICS 

199 975.00 

- 

04 

implementing 
N° 

74 
2015 
CHAFEA/2015/Healt
h/24 
FWC 
CHAFEA/2013/Healt
h/01 
ECORYS 

-  Lot  02 

- 

Total 

Thematic priority: 

4.5 Implementation of Union legislation in the fields of human 
tissues  and  cells    blood    human  organs    medical  devices  
medicinal products  and patients’ rights in cross-border health 
care 

199 975.00 

User reference 

Title 

Amount EUR 

ORGAN DONATION 

199 030.00 

2015  74  05  RFS  14  - 
CHAFEA/2015/HEA
LTH/25 
N°EAHC/2013/HEA
LTH/01)  LOT1 
(NIVEL) 

(FWC 

-  

Total 

Objective's 
description: 

5.  IT  /  dissemination  (Horizontal  action  related  to  all 
objectives)  

199 030.00 

Thematic priority: 

horizontal IT / dissemination 

User reference 

Title 

Amount EUR 

- 

HEALTH REPORTS-BIG DATA 

78 260.00 

05 

73 
2015 
CHAFEA/2015/HEA
LTH/21 
(IMPLEMENTING 
FWC 
N°EAHC/2013/HEA
LTH/01 
SOGETI)  

LOT1 

60 

 
 
 
 
 
 
 
 
2015  75  01    -  RFS 
CHAFEA/2015/HEA
LTH/31 
(FWC 
N°CHAFEA/2013/HE
ALTH/14) 
(NOOKOM) 

-  

Total 

CHAFEA 
CALLS 
TENDER 

TOTAL 
FOR 

EXTERNAL 
COMMUNICATION 

ASSISTANCE 

FOR 

EXTERNAL 

200 000.00 

278 260.00 

5 890 424.70 

61 

 
 
 
 
 
 
 
 
Financial 
Instrument 

Objective's 
description: 

SANTE Calls for tenders by objective 

1. Promote health  prevent diseases and foster supportive 
environments  for  healthy  lifestyles  taking  into  account 
the 'health in all policies' principle 

Thematic priority: 

1.1 Cost-effective promotion and prevention measures in 
line  in  particular  with  the  Union  strategies  on  alcohol 
and nutrition… 

User reference 

Title 

Amount EUR 

150 000.00 

493 611.61 

643 611.61 

Amount EUR 

11 000.00 

11 000.00 

- 

17.030100 

C4 
- 
WEBMASTER  AND  USER  ASSISTANT  HEALTH 
POLICY FORUM - SC204 

-  NOVACOMM-AUSY 

PROMOTIONAL 

-  EXTERNAL  ASSISTANCE 
-  17.030100 
C4 
ORGANISATION 
AND 
COMMUNICATION  ACTIVITIES  AND  EVENTS 
LINKED TO THE EU ANTI-TOBACCO CAMPAIGN 
-  JWT  -CONSORTIUM  COM28  -  AMENDMENT  TO 
17030100/14/698892 

Total 

Thematic priority: 

1.4 Support cooperation and networking in the Union in 
relation to preventing and improving the response to 
chronic diseases… 

User reference 

Title 

C1 - 17030100 - CONFERENCE ON CHRONIC 
DISEASE - NOV 2015 - BXL - DEG 

Total 

62 

 
 
 
 
 
 
 
  
 
 
 
 
 
 
Thematic priority: 

1.5 Actions required by or contributing to the 
implementation of Union legislation in the field of 
tobacco products… 

User reference 

Title 

D4 - 17.030100 - BUTCHER & GUNDERSEN - 
CREATION TECHNICAL FILES FOR COMINED 
WARNINGS - ART 10 OF THE TOBACCO 
PRODUCTS DIRECTIVE - COMPL 

 Total 

Objective's 
description: 

3. Contribute to innovative  efficient and sustainable 
health systems 

Amount EUR 

15 580.00 

15 580.00 

Thematic priority: 

3.4. Provide expertise and share good practices to assist 
Member States undertaking health system reforms … 

User reference 

Title 

Amount EUR 

Total 

Thematic priority: 

D3 - INDEMNITIES FOR EXPERTS PANEL ON 
EFFECTIVE WAYS OF INVESTING IN HEALTH -
JAN 2015 -MAY 2016 

3.6 Implementation of Union legislation in the field of 
medical devices  medicinal products and cross-border 
health care 

320 000.00 

320 000.00 

User reference 

Title 

Amount EUR 

SC 2807 - CF - PROJECT MANAGER FOR EMP 

OF 1028 - RENEWAL REDHAT LICENSES 

SC 241 - RD - TEAM COORDINATOR FOR EMP 

SC 3448 - DB - APPLICATION ARCHITECT FOR 
EMP 

D5 - SI2.714258 - COMPLEMENTARY 
COMMITMENT TO SI2.684926 FOR  VAT PAY - 
ICH STEERING COMMITTEE 8 AU 13 NOVEMBRE 
2014 -  

68 308.00 

3 000.00 

76 688.46 

156 312.00 

6 359.40 

63 

 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
  
D5 - 17.030100 - TECHNOPOLIS - STUDY ON THE 
ECONOMIC IMPACT OF THE PAEDIATRIC 
REGULATION 

179 984.50 

5 000.00 

1 000.00 

2 000.00 

72 500.00 

2 500.00 

3 000.00 

39 464.00 

2 000.00 

3 000.00 

9 000.00 

3 500.00 

1 000.00 

3 000.00 

243 775.00 

136 866.80 

300 000.00 

OF 1531 - CD - MAINTENANCE VARIOUS 
SOFTWARE 

OF 1532 - MAINTENANCE VARIOUS SOFTWARE 

OF 1536 - EN - NEW SPHERE LICENSES FOR 
SERVER VIRTUALISATION 

SC 4468 - PS - PROJECT MANAGER FOR IT 
HEALTH 

OF 35 - NEW APPSCAN LICENSE 

OF 1617 - CD - RENEWAL MAINTENANCE 
REMOTE APPLICATION 

OF 1429 - IDOL LICENSES YEAR 2 

OF 1631 - NEW NEOSENSE LICENSE 

SC 1632 - CONFIGURATION OF NEOTYS 
APPLICATION 

OF 1691 - PURCHASE ELASTICSEARCH 
DEVELOPMENT SUPPORT 

OF 1696 - VARIOUS SOFTWARE 

OF 36 - RENEWAL SUBSCRIPTION IBM SECURITY 
APPSCAN 

OF 772 - PURCHASE PRO DESK PCS FOR SANTE 
BRUSSELS 

B5- 17.030100 - EVALUATION COSTS EMA - 
SANTE/2016/B5/021 - RAND 

GROW/R3 - CS 2862 - CC DI/7335 - SAITAS - 
INNOVATIA  

GROW/D4/2015 - TECHNICAL AND SCIENTIFIC 
SUPPORT IN THE FIELD OF MEDICAL DEVICES II 
- ADMINISTRATIVE ARRANGEMENT BETWEEN 

64 

 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
DG GROW AND DG JRC 

GROW/R3 - CS 4504 - CC DI/7335 - PROCTER - 
INNOVATIA 

Total 

Thematic priority: 

3.7. Foster a health information and knowledge system 
to contribute to evidence-based decision-making 

User reference 

Title 

C2 - 17.030100 - COGENERIS - 2 LAYER WEB-
BASED SUMMARY BASED ON SCIENTIFIC 
OPINION OF SCIENTIFIC COMMITTEES - 
COGENERIS 

C2 - 17.030100 - BRE - LITERATURE REVIEW ON 
SYNTHETIC BIOLOGY 

C2 - LITERATURE REVIEW ON SUNBEDS 

D3 - 17.030100 - BRE - DATA MINING STUDY ON 
ACCESS TO HEALTHCARE FOR THREE 
VULNERABLE GROUPS - DEG 

C2 - 17.030100 - BRE - LITERATURE SEARCH ON 
TOY MATERIAL INGESTED BY CHILDREN 

C2 - 17.030100 - BRE - LITERATURE SEARCH ON 
HYDROXYAPATITE - SANTE/2015/C2/025 

C2 - 17.030100 - NOVACOMM - 2 WEB/VISUAL 
DESIGNERS FOR SCIENTIFIC COMMITTEES AND 
HEALTH EU NEWSLETTER 

SI2.715518 - C2 - WORKSHOP ON SYNTHETIC 
BIOLOGY - 10 DEC LUXEMBOURG - 

C2 -  17030100 - SCIENTIFIC COMMITTEES - 
INDEMNITIES PAID TO EXPERTS 2015  - COMPL 

Total 

65 

12 948.60 

1 331 206.76 

Amount EUR 

2 500.00 

14 768.00 

10 583.00 

10 582.50 

10 470.00 

9 603.00 

224 000.00 

30 000.00 

150 000.00 

462 506.50 

 
 
 
  
 
 
 
  
  
  
  
  
  
  
  
 
 
 
Objective's 
description: 

4. Facilitate access to better and safer healthcare for 
Union citizens 

Thematic priority: 

4.1 Support the establishment of a system of European 
reference networks for patients with conditions requiring 
highly specialised care… 

User reference 

Title 

Amount EUR 

SERVICE CONTRACT SANTE/2015/A4/028 - OPEN 
NCP LOAD AND SECURITY TESTING 

SC 2943 - MF - PROJECT MANAGER FOR 
HORIZONTAL ACTIONS 

SC 3193 - CBT - BUSINESS INTELLIGENCE 
ANALYST FOR PUBLIC HEALTH 

SC 3202 - GQ - SECURITY CONSULTANT FOR 
RASFF 

SC 3130 - CD - APPLICATION ARCHITECT FOR 
PUBLIC HEALTH 

SC 3966 - OM - DATABASE DEVELOPER FOR 
PUBLIC HEALTH 

OF 1531 - CD - MAINTENANCE VARIOUS 
SOFTWARE 

14 880.00 

50 000.00 

25 000.00 

30 000.00 

67 376.00 

96 011.33 

9 512.93 

OF 1532 - MAINTENANCE VARIOUS SOFTWARE 

1 000.00 

SC 4468 - PS - PROJECT MANAGER FOR IT 
HEALTH 

OF 35 - NEW APPSCAN LICENSE 

OF 1631 - NEW NEOSENSE LICENSE 

OF 1644 - RENEWAL MAINTENANCE VARIOUS 
SOFTWARE 

SC 1632 - CONFIGURATION OF NEOTYS 
APPLICATION 

OF 1696 - VARIOUS SOFTWARE 

71 206.00 

2 500.00 

2 000.00 

4 385.97 

3 000.00 

3 500.00 

66 

 
 
 
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
OF 36 - RENEWAL SUBSCRIPTION IBM SECURITY 
APPSCAN 

1 000.00 

381 372.23 

5 744 988.82 

Total 

SANTE TOTAL 
CALLS FOR TENDER 

Other actions 

EUR 1 445 177.4 was earmarked for other actions in 2015. The ‘other actions’ include experts’ fees, 

for example: 

  The expert panel on effective ways of investing in health 

  For experts carrying out system inspection on pharmaceutical ingredients 

  For experts participating in the international conferences on the harmonisation of technical 

requirements for the registration of pharmaceuticals for human and veterinary uses 

This also includes cost of administrative agreements with the Joint Research Centre and covers the 

Commission’s  membership  fee  to  the  European  Observatory  on  Health  Systems  and  Policies.  For 

more information on what specific actions fell under the banner ‘other actions’ (please see the table 

below for further reference). 

Financial Instrument 

CHAFEA other actions by objective 

Objective's description: 

3. Contribute to innovative  efficient and sustainable health systems 

Thematic priority: 

3.7. Foster a health information and knowledge system to contribute 
to evidence-based decision-making 

User reference 

Title 

Amount EUR 

EUROPEAN 
OBSERVATORY  ON 
HEALTH SYSTEMS & 
POLICY 

CHAFEA 
OTHER ACTIONS 

TOTAL 

EUROPEAN  OBSERVATORY  ON  HEALTH  SYSTEMS  & 
POLICY 

500 000.00 

500 000.00 

67 

 
 
 
  
 
 
 
 
 
 
 
 
Financial Instrument 

SANTE other actions by objective and priority 

Objective's description: 

1.  Promote  health,  prevent  diseases  and  foster  supportive  environments  for 
healthy lifestyles taking into account the 'health in all policies' principle 

Thematic priority: 

1.1  Cost-effective  promotion  and  prevention  measures  in  line,  in  particular, 
with the Union strategies on alcohol and nutrition… 

User reference 

Title 

Amount EUR 

SI2.723392 - C4 -  HEALTHY EATING AND PHYSICAL ACTIVITY AND 
ACOHOL RELATED HARMS 

450 000.00 

Total 

 450 000.00 

Objective's description: 

3. Contribute to innovative, efficient and sustainable health systems 

Thematic priority: 

3.6 Implementation of Union legislation in the field of medical devices, 
medicinal products and cross-border health care 

User reference 

Title 

Amount EUR 

F5 -  REIMBURSEMENT OF EXPERTS' EXPENSES FOR JOINT 
ASSESSMENTS - MEDICAL DEVICES - MOD MT 

D5 - MEETINGS EU EXPERTS IN ICH - ENG COMPLEMENTAIRE-
DEG- 

D6 - 17030100 - TRAVEL COSTS FOR EXPERTS COMING TO VICH 
MEETINGS IN 2015 

B5 - SI2.729053 - MEMBERSHIP FEE TO THE ICH - DEG -  

147 000.00 

295 000.00 

25 000.00 

28 177.40 

495 177.40 

945 177.40 

Total 

SANTE TOTAL OTHER 
ACTIONS 

68 

 
 
 
 
 
 
 
 
 
 
 
  
  
  
 
 
DETAILED OVERVIEW OF THE REPORTING YEAR 

1.  Funding per thematic priority and financial instrument 

Objective's description 

1. Promote health, prevent diseases and foster supportive environments for healthy lifestyles taking into account the 'health in all policies' 
principle 

Third 
Thematic priorities 

Health 

Programme 

Projects 

Joint Actions 

Operating 
Grants 

Direct 
Grants 

Direct  Grants 
SANTE 

Presid. Conf.  Calls 

for 

tenders 

for 

Calls 
SANTE 

tenders 

Other Actions 

Other  Actions 
SANTE 

 Total 

1.1 Cost-effective promotion and 
prevention measures in line, in 
particular, with the Union strategies 
on alcohol and nutrition… 

1.3 Support effective responses to 
communicable diseases such as 
HIV/AIDS, tuberculosis and 
hepatitis… 

1.5 Actions required by, or 
contributing to, the implementation 
of Union legislation in the field of 
tobacco products, advertising and 
marketing 

1.6 Health information and 
knowledge system 

1.4 Support cooperation and 
networking in the Union in relation 
to preventing and improving the 
response to chronic diseases… 

935 260.39 

0.00 

2 105 541.00 

600 000.00 

0.00 

0.00 

0.00 

643 611.61 

0.00 

450 000.00 

4 734 413.00 

 2 922 795,89  0.00 

352 582.00 

0.00 

0.00 

0.00 

1 999 992.00 

0.00 

0.00 

0.00 

  5 275 309,89 

0.00 

0.00 

0.00 

0.00 

0.00 

0.00 

800 000.00 

15 580.00 

0.00 

0.00 

815 580.00 

0.00 

0.00 

0.00 

375 000.00 

74 037.24 

0.00 

0.00 

0.00 

0.00 

0.00 

0.00 

766 731.00 

0.00 

0.00 

0.00 

0.00 

11 000.00 

0.00 

0.00 

0.00 

449 037.24 

777 731.00 

Total 

 3 857 996,28  0.00 

3 224 854.00 

975 000.00 

74 037.24 

0.00 

2 799 992.00 

670 191.61 

0.00 

450 000.00 

 12 052 071,13 

69 

 
 
 
 
 
 
Objective's description 

2.  Protect  Union  citizens  from  serious  cross-border 
health threats 

Third  Health  Programme 
Thematic priorities 

Projects 

Joint Actions  Operating 

Grants 

Direct 
Grants 

Direct  Grants 
SANTE 

Presid. 
Conf. 

Calls 
tenders 

for 

Calls  for  tenders 
SANTE 

Other Actions  Other  Actions 

 Total 

SANTE 

2.2  Support  capacity-building 
in 
against 
Member States 

threats 

health 

0.00 

0.00 

0.00 

0.00 

0.00 

0.00 

1 398 928.80 

0.00 

0.00 

0.00 

1 398 928.80 

Total 

0.00 

0.00 

0.00 

0.00 

0.00 

0.00 

1 398 928.80 

0.00 

0.00 

0.00 

1 398 928.80 

70 

 
 
 
 
 
 
 
 
 
 
 
 
 
Objective's description 

3. Contribute to innovative, efficient and sustainable health 
systems 

Third 
Thematic priorities 

Health 

Programme 

Projects 

Joint Actions 

Operating 
Grants 

Direct 
Grants 

Direct  Grants 
SANTE 

Presid. 
Conf. 

Calls 
tenders 

for 

Calls  for  tenders 
SANTE 

Other Actions 

Other  Actions 
SANTE 

 Total 

3.1  Support  voluntary  cooperation 
between  Member  States  on  health 
technology assessment 

3.3 Support the sustainability of the 
health  workforce  by  developing 
effective 
workforce 
health 
forecasting and planning  

3.4.  Provide  expertise  and  share 
good  practices  to  assist  Member 
States  undertaking  health  system 
reforms … 

3.5.  Address  health  issues  in  an 
ageing society  

3.6 
Implementation  of  Union 
legislation  in  the  field  of  medical 
devices,  medicinal  products  and 
cross-border health care 

3.7. Foster a health information and 
knowledge  system  to  contribute  to 
evidence-based decision-making 

0.00 

11 999 798.74 

0.00 

0.00 

0.00 

0.00 

0.00 

0.00 

0.00 

0.00 

11 999 798.74 

0.00 

0.00 

0.00 

150 000.00 

0.00 

0.00 

0.00 

0.00 

0.00 

0.00 

150 000.00 

0.00 

0.00 

0.00 

0.00 

0.00 

0.00 

724 960.00 

320 000.00 

0.00 

0.00 

1 044 960.00 

 3 395 207,18  3 442 591.13 

0.00 

0.00 

0.00 

0.00 

0.00 

0.00 

0.00 

0.00 

6 837 798,31 

0.00 

849 487.69 

0.00 

1 100 000.00 

0.00 

0.00 

0.00 

1 331 206.76 

0.00 

495 177.40 

3 775 871.85 

0.00 

0.00 

0.00 

0.00 

46 710.05 

0.00 

289 278.90 

462 506.50 

500 000.00 

0.00 

1 298 495.45 

Total 

 3 395 207,18  16 291 877.56 

0.00 

1 250 000.00 

46 710.05 

0.00 

1 014 238.90 

2 113 713.26 

500 000.00 

495 177.40 

25 106 924,35 

71 

 
 
 
 
 
 
 
 
 
  
  
 
 
 
Objective's description 

4. Facilitate access to better and safer healthcare for Union 
citizens 

Third 
Thematic priorities 

Health 

Programme 

Projects 

Joint Actions 

Operating 
Grants 

Direct 
Grants 

Direct  Grants 
SANTE 

Presid. 
Conf. 

Calls 
tenders 

for 

Calls  for  tenders 
SANTE 

Other Actions 

Other  Actions 
SANTE 

 Total 

0.00 

0.00 

0.00 

0.00 

0.00 

0.00 

0.00 

381 372.23 

0.00 

0.00 

381 372.23 

4.1  Support  the  establishment  of  a 
system  of  European 
reference 
patients  with 
networks 
conditions 
highly 
specialised care… 

requiring 

for 

0.00 

1 499 848.04 

792 021.00 

0.00 

0.00 

0.00 

0.00 

0.00 

0.00 

0.00 

2 291 869.04 

0.00 

0.00 

735 645.00 

0.00 

0.00 

20 434.90 

199 975.00 

0.00 

0.00 

0.00 

956 054.90 

0.00 

0.00 

0.00 

340 000.00 

0.00 

100 000.00 

0.00 

0.00 

0.00 

0.00 

440 000.00 

1 456 597.00  0.00 

253 000.00 

0.00 

0.00 

0.00 

199 030.00 

0.00 

0.00 

0.00 

1 908 627.00 

4.2  Coordinated  action  at  Union 
level  in  order  to  effectively  help 
patients affected by rare diseases 

4.3  Strengthen  collaboration  on 
patient  safety  and  quality  of  health 
care 

4.4  Improve  the  prudent  use  of 
antimicrobial agents and reduce the 
practices that increase antimicrobial 
resistance 

4.5 
Implementation  of  Union 
legislation  in  the  fields  of  human 
tissues  and  cells,  blood,  human 
organs,  medical  devices,  medicinal 
products,  and  patients’  rights  in 
cross-border health care 

4.6  Health 
knowledge system  

information 

and 

0.00 

0.00 

0.00 

150 000.00 

0.00 

0.00 

0.00 

0.00 

0.00 

Total 

1 456 597.00  1 499 848.04 

1 780 666.00 

490 000.00 

0.00 

120 434.90 

399 005.00 

381 372.23 

0.00 

0.00 

0.00 

150 000.00 

6 127 923.17 

72 

 
 
 
 
 
 
 
 
 
 
Third  Health  Programme 
Thematic priorities 

Projects 

Joint Actions  Operating 

Direct 
Grants 

Direct  Grants 
SANTE 

Presid. 
Conf. 

Calls 
tenders 

for 

Calls  for  tenders 
SANTE 

Other Actions  Other Actions 

 Total 

Objective's description 

5. IT / dissemination (Horizontal action related to all 
objectives)  

horizontal IT / dissemination 

0.00 

Total 

0.00 

0.00 

0.00 

Grants 

0.00 

0.00 

SANTE 

0.00 

0.00 

2 857 971.72 

2 857 971.72 

0.00 

0.00 

0.00 

0.00 

0.00 

0.00 

278 260.00 

2 579 711.72 

278 260.00 

2 579 711.72 

0.00 

0.00 

73 

 
 
 
 
 
 
 
 
 
 
 
 
Objective's description 

6.  Support  Member  States  under  particular  migratory  pressure  in  their  response  to  health  related  challenges  (Horizontal 
action related to objectives 1 and 2) 

Third Health Programme 
Thematic priorities 

Projects 

Joint Actions  Operating 

Direct 
Grants 

Direct  Grants 
SANTE 

Presid. 
Conf. 

Calls 
tenders 

for 

Calls  for  tenders 
SANTE 

Other Actions  Other Actions 

 Total 

horizontal migration 

6 234 199.58  0.00 

Total 

6 234 199.58  0.00 

1 000 000.00  0.00 

1 000 000.00  0.00 

0.00 

0.00 

0.00 

0.00 

0.00 

0.00 

0.00 

0.00 

Grants 

0.00 

0.00 

SANTE 

0.00 

0.00 

7 234 199.58 

7 234 199.58 

Projects 

Joint Actions  Operating 

Grants 

Direct 
Grants 

Direct  Grants 
SANTE 

Presid. 
Conf. 

Calls 
tenders 

for 

Calls for tenders 
SANTE 

Other Actions  Other Actions 

 Total 

SANTE 

TOTAL 

14 944 000.04  17 791 725.60 

5 005 520.00  3 715 000.00  120 747.29 

120 434.90 

5 890 424.70 

5 744 988.82 

500 000.00 

945 177.40 

54 778 018.75 

TOTAL ACTIONS COMMITTED BY CHAFEA UNDER AWP 2015 

47 967 105.24 

TOTAL ACTIONS COMMITTED BY DG SANTE UNDER AWP 2015 

   6 810 913.51 

TOTAL COMMITTED                                         

 54 778 018.75 

74